<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:owl="http://www.w3.org/2002/07/owl#"
 xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
 xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
<owl:Ontology rdf:about="">
 <owl:imports rdf:resource="http://www.biopax.org/release/biopax-level3.owl#" />
</owl:Ontology>

<bp:BiochemicalReaction rdf:about="http://pathwaycommons.org/pc12/BiochemicalReaction_899fcce638d0b58bd8a85acaae7826d8">
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f102777cd633a33cca56e9649a56be56" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a2080998d8432aa757cca7ffb9286a9b" />
 <bp:right rdf:resource="http://pathwaycommons.org/pc12/Protein_e5fbb0282f2caebd3efb3d3b6c65d628" />
 <bp:left rdf:resource="http://pathwaycommons.org/pc12/Protein_90bf205d59d781c725fe08adcb93f27c" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/BiochemicalReaction_899fcce638d0b58bd8a85acaae7826d8</bp:comment>
 <bp:conversionDirection rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEFT_TO_RIGHT</bp:conversionDirection>
</bp:BiochemicalReaction>

<bp:BiochemicalReaction rdf:about="http://pathwaycommons.org/pc12/BiochemicalReaction_7e3eaefa3f956a92ba24560ac3b09ff6">
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_00ddc0b2d3f3dacd37f4ad0afea3385e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_bfef3f78240662f3757ef5b2b0485a80" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_1e06e06ea7b6fb1e98657aefd7928f74" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_fa1e3c016b96a89a58012044e2016fff" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_76bcdf2ad44c06fcdf0cc8116be550b4" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_7fefcf160c5da2b11fb0b5c27967d7f4" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_65174f81df69e5d6b62e4a6a5f9b43ae" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_aecd319845fb832a0398477298490162" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f817fdf6201137786d2b4746bd0e39cc" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_8904c60a812f289f53e222da18171fe3" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_8ca856c619a36d53852d65efaa36c4d8" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f0a8824f333259b3e02b82e90aa61082" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f157bdb2993dcfe3b4e5f104a88e8ca5" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_bad210b9258fb8d8c49ed088b0824f9d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_23743c592e97b3e0c0c3d523a9c27416" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_8b9b2f0f54bcf3e03bf56985edff2b15" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_d2427a13ffe430d2d2446081f4f8a106" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_53e00bc8ba4523daa2fa4351a3cce8dc" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a98f99b052bbbd62c1dc4d07c0d96613" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_d67a4a9eba384fcd7d7a7b235f5f3886" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_35f958163d4704a52557ddc621c1a2cf" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a3d29057349ab78b1f95116a8db81764" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_88e2c591d593ed013ca24a31199a1184" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_0afffb3e78f9d5a551adaaa817316fdd" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_36deceda7671918181a7731de75ae942" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_2527346a60e5f125c2ee6cf89e3c4127" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_16c3d9c359cd73e925b1acc65545f17d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_123cc86844e0284ebfc20a089120c9dd" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_ee0210c286807f1c5baf9396c9bd7d45" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_813069d7087b21b319714e2c925b3ae2" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_97cbb3128476a1b5c80692e3f18b1573" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_99e28f0141c2908394e869c32ea5b424" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_84dfe4fb4ce504ec5bb4f5c44d1cfcae" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_8be9715da55a6ddac700f6aaf0bcce71" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_b41b70000563924cb6c56088443e44ef" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f833d1f60763c902bc71865e050746de" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_2baf8bdafb3124a60f00a31d56a8e12b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_bbbadc6a88bcc5942d61cbe25684dee6" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f7d26507c7a88d28213ddf602d0f4ee3" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_aefdb089768813838ebbbbeab792249a" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_1a5bd2f6f72b401a7667a7b60f384792" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_00b30b7be48068cfe0c725695766c244" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_ce629583e9f964f905b7439da1d60a1d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_2c4c367ae86e6f3a073820fb6c00f421" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_86cf506d82bf7c7681a9f5f758a537f7" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_af48b4cf2e2cef2368a160c396aafc88" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_413fa2e1a96685724fc9be4707c8e671" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_bbec2a0704c5d1fcfc1f7e5446200b14" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_35647107cc9901f67ca6990dfc8f9771" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_0f59d126fefce868fc8d21072b3c4211" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_1d0ca4583588a30b832d428c04d5da43" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_bc2db127a925dfb50367579c423d601a" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_c61a88e28c312d7fccd0871aa610b1d2" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_7cb05f1aecb30419dec9bb4ee6d43509" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_3913e3693485176d59cfcd643450998d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_7a61102de68f980493fe1b0fb00e7c2c" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_8db79d3819878fce1b849711ae6ab24f" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_da33f782974b8542632cfac0bfdf8bf9" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_0d85a224f3f11fbcba03d2d1f7dc9e61" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_8468612c8396d9ca971656cad0ba33e6" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_5afaeff163cb9582329948fde4fabf63" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_e796264d30864011f6530b8b64c01394" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_aa3ad25fe666a6f289a194c57039e1b6" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_1d8960d084e81f6e5ad15f66f6488c27" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_6080819dee1e6bd7379472c7aef48272" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f1656cc3e8f7fa8e4ed205582a96c53e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_787567869d58ddcefd5217d144197777" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_c0c27c05da31297cc43600af30d0564d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_37b71da8468846903c8286b0a58ac70b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_20bf9b7864c0e525c8763412f1fa2f9b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_cc0db9f8a4794d077843be44a0b4385c" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_83327167b849c1611499b0ab3565bd9d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_2e0f3858088328eb63c2a29837f44c9b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_d966642df0d0f7db156760914f92c78a" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_d66a4e773830af69551f0ee3824e9d24" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f65e294c40c4fcb2f91465410805113e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_cf8c7bb3a8c30f69232144dbc7cf0f2e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_5b9bf12ea5718a075cc8edb6a11e5593" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_8c59ddf61ae4f180863177aab7b1c02e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f69befe7a7c31b6cfd95b642c375c04d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f9dfab2b67a5704ae2424a689175a4c0" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_3ae959782555281dc9ce99b029b9a3f7" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_e0b9f6b1e7c2962a26c501a826755cc5" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_e15a3fab704a5c95a988c52863b4c741" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_7ef986d5fb34cf8e480d79451d4b1e3a" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f90c7682e3b758813245d9de8ea0ccd0" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_23f3a687f6bfd8a3c3161c0db19f659a" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_15800912e47ca49c5b11f7e8b570340e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_cf27fb1da9e471e1bc15f5d495fb0c12" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a9572d7333356aa1369660834d9d028d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f0a611be32b23ae3d4dd9c6af8b98ce6" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_6705788ddac21dcdc0db2f59f1564d0c" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_4b64dd74821979a18e0c00b30cf92149" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_cead2e4a445aa86c9489817d17bcb07e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_b850b4e60cc6108d1f97598d191e2721" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_6102340760ef8d36849309f3538c2cf9" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_c671fa9076c353625f6bb68e1e0d4bf1" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_ae783e7d16d683b30e88b2e577d28257" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_315f05d1b51305f2898e790f57b035bd" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_880f4b6855fe65e87ac2c7092816497a" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_6eeb5d765148f96f6882b14f72ad575e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_4015d6ead1188fb14d3f23f45acfd6b6" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_88c7a2d9c534b420498edfc6279d7255" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_e3e57c05dc5f8ef7370de45f70f759e3" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_b2215a265991d55b70aa61160cba622d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_9cf75c6c5ed05c760a33bc9612a2a8ac" />
 <bp:right rdf:resource="http://pathwaycommons.org/pc12/Protein_916b4ee63ca3b47861ef4f1a02b179bd" />
 <bp:left rdf:resource="http://pathwaycommons.org/pc12/Protein_655b60773d189deacc144b82775c8096" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/BiochemicalReaction_7e3eaefa3f956a92ba24560ac3b09ff6</bp:comment>
 <bp:conversionDirection rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEFT_TO_RIGHT</bp:conversionDirection>
</bp:BiochemicalReaction>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/29760653">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2018</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">29760653</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CK2 Phosphorylating I/SET Mediates Tau Pathology and Cognitive Impairment.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=650545715</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_0a44b539d7044a2ed6a044d69aaa2e50">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/25159151" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_0a44b539d7044a2ed6a044d69aaa2e50</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_fa1e3c016b96a89a58012044e2016fff">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16464956" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_fa1e3c016b96a89a58012044e2016fff</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/18691976">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">18691976</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3146361</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/22496350">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2012</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">22496350</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=28701806</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_698fd962-0249-4a04-96eb-921232f21cb2http___www_phosphosite_org_phosphosite_owl_recid_4147630">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_698fd962-0249-4a04-96eb-921232f21cb2http___www_phosphosite_org_phosphosite_owl_recid_4147630</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3938; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, heart/untreated; &lt;b&gt;Disease:&lt;/b&gt; -; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4147630</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a2080998d8432aa757cca7ffb9286a9b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17296736" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a2080998d8432aa757cca7ffb9286a9b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_c2d71a067a0c4cee1fd91e4a080d4899">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/26429909" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_c2d71a067a0c4cee1fd91e4a080d4899</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_aecd319845fb832a0398477298490162">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20506302" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_aecd319845fb832a0398477298490162</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16464956">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2006</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16464956</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=7681</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_8ca856c619a36d53852d65efaa36c4d8">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24301651" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_8ca856c619a36d53852d65efaa36c4d8</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Catalysis rdf:about="http://pathwaycommons.org/pc12/Catalysis_1849d12874a99d4b213cc34819380ec5">
 <bp:controller rdf:resource="http://pathwaycommons.org/pc12/Protein_f3c418ddcf2a8a07c60891aca3529587" />
 <bp:controlled rdf:resource="http://pathwaycommons.org/pc12/BiochemicalReaction_7e3eaefa3f956a92ba24560ac3b09ff6" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Catalysis_1849d12874a99d4b213cc34819380ec5</bp:comment>
</bp:Catalysis>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_58492f0f856b848096a5f25fb52bbc37">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_d8219bc2-34a9-4683-ac58-61551ab304afhttp___www_phosphosite_org_phosphosite_owl_recid_3359218" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_58492f0f856b848096a5f25fb52bbc37</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_bad210b9258fb8d8c49ed088b0824f9d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/29760653" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_bad210b9258fb8d8c49ed088b0824f9d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Catalysis rdf:about="http://pathwaycommons.org/pc12/Catalysis_aac3797f0092aa76f27cb9d98f239d32">
 <bp:controller rdf:resource="http://pathwaycommons.org/pc12/Protein_cabd1e2e223e7c67ec14cf7bd044dfd1" />
 <bp:controlled rdf:resource="http://pathwaycommons.org/pc12/BiochemicalReaction_2f9032a2a45978cc0f1e28630f2887cf" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Catalysis_aac3797f0092aa76f27cb9d98f239d32</bp:comment>
</bp:Catalysis>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_dca25ce4-4e0a-4792-9542-1c7bcf6178d6http___www_phosphosite_org_phosphosite_owl_recid_3360252">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_dca25ce4-4e0a-4792-9542-1c7bcf6178d6http___www_phosphosite_org_phosphosite_owl_recid_3360252</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3907; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, liver/untreated; &lt;b&gt;Disease:&lt;/b&gt; liver cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3360252</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/18779572">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">18779572</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4321200</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_c41d3b53dd13fc65aa167ba1342ab94b">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_7b014925-1378-4ed4-9650-d3d25697b1ffhttp___www_phosphosite_org_phosphosite_owl_recid_9390970" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_c41d3b53dd13fc65aa167ba1342ab94b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_35f958163d4704a52557ddc621c1a2cf">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15994305" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_35f958163d4704a52557ddc621c1a2cf</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_88e2c591d593ed013ca24a31199a1184">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/12226093" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_88e2c591d593ed013ca24a31199a1184</bp:comment>
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_e5fbb0282f2caebd3efb3d3b6c65d628">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FANCE</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FANCE (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_e5fbb0282f2caebd3efb3d3b6c65d628</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_36deceda7671918181a7731de75ae942">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/26692334" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_36deceda7671918181a7731de75ae942</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_f7e42f9c-96bd-469d-9774-f43b12048f87http___www_phosphosite_org_phosphosite_owl_recid_3358926">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_f7e42f9c-96bd-469d-9774-f43b12048f87http___www_phosphosite_org_phosphosite_owl_recid_3358926</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4016; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, gastrointestinal tract/untreated; &lt;b&gt;Disease:&lt;/b&gt; gastric cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3358926</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_2527346a60e5f125c2ee6cf89e3c4127">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/28758999" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_2527346a60e5f125c2ee6cf89e3c4127</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_0b48435062bd1bc4a500489eaaf0ac00">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18847512" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_0b48435062bd1bc4a500489eaaf0ac00</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/22942356">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2012</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">22942356</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Investigation of receptor interacting protein (RIP3)-dependent protein phosphorylation by quantitative phosphoproteomics.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=28701805</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_703cd2a28612abcf069a58a8693f3d24">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLM</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLM (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_703cd2a28612abcf069a58a8693f3d24</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_20b60462ccc360253434dbe5c5200f64">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_c1c595c4-aeb8-4655-af44-1eb93165dc77http___www_phosphosite_org_phosphosite_owl_recid_3360074" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_20b60462ccc360253434dbe5c5200f64</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/15190058">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2004</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">15190058</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Promotion of hyperphosphorylation by frontotemporal dementia tau mutations.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4133</bp:url>
</bp:PublicationXref>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_molecular_interactions_ontology_MI_0427">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MI:0427</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">molecular interactions ontology</bp:db>
</bp:UnificationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_b9856974a50645815a89ea8f1db19032">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20097925" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_b9856974a50645815a89ea8f1db19032</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_3f828b989a839ca7899ee96bd1fb0b32">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/2026614" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_3f828b989a839ca7899ee96bd1fb0b32</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_7f6e5b75cc5707ce38a7e95982eba4f6">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/22617229" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_7f6e5b75cc5707ce38a7e95982eba4f6</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_ee0210c286807f1c5baf9396c9bd7d45">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/28814543" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_ee0210c286807f1c5baf9396c9bd7d45</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24301651">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24301651</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FLAP pharmacological blockade modulates metabolism of endogenous tau in vivoÂ .</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=30292213</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16397900">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2006</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16397900</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=7674</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20466736">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20466736</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer&apos;s disease.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=15754007</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_97cbb3128476a1b5c80692e3f18b1573">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16787414" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_97cbb3128476a1b5c80692e3f18b1573</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_84dfe4fb4ce504ec5bb4f5c44d1cfcae">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24073234" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_84dfe4fb4ce504ec5bb4f5c44d1cfcae</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_99e28f0141c2908394e869c32ea5b424">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18315566" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_99e28f0141c2908394e869c32ea5b424</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_8be9715da55a6ddac700f6aaf0bcce71">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19451179" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_8be9715da55a6ddac700f6aaf0bcce71</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_molecular_interactions_ontology_MI_0421">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MI:0421</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">molecular interactions ontology</bp:db>
</bp:UnificationXref>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_Q61214">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Q61214</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">uniprot knowledgebase</bp:db>
</bp:UnificationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_051dbd245451fdf9caa719c11430f9ea">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/25850435" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_051dbd245451fdf9caa719c11430f9ea</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_96435395-b708-4d1b-9799-7a096f427fc3http___www_phosphosite_org_phosphosite_owl_recid_3359334">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_96435395-b708-4d1b-9799-7a096f427fc3http___www_phosphosite_org_phosphosite_owl_recid_3359334</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3352; &lt;b&gt;Year:&lt;/b&gt; 2007; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, colon/untreated; &lt;b&gt;Disease:&lt;/b&gt; colorectal cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359334</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/25084196">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2014</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">25084196</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">S137 phosphorylation of profilin 1 is an important signaling event in breast cancer progression.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=35516250</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_a8a43e3e64cead6a052cc0eb27e76505">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LY96</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LY96 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_a8a43e3e64cead6a052cc0eb27e76505</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_aefdb089768813838ebbbbeab792249a">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18725412" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_aefdb089768813838ebbbbeab792249a</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_00b30b7be48068cfe0c725695766c244">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16464956" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_00b30b7be48068cfe0c725695766c244</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/12765608">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2003</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">12765608</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cdk5 is a key factor in tau aggregation and tangle formation in vivo.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2210</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21367866">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21367866</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=20834108</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/15249677">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2004</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">15249677</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer&apos;s disease.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=5354409</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/17296736">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">17296736</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9371</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f610e620150f52982e652ab3f8f44047">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/12176732" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f610e620150f52982e652ab3f8f44047</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_413fa2e1a96685724fc9be4707c8e671">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18052981" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_413fa2e1a96685724fc9be4707c8e671</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_44aa6afedcb89ee63968465c4eaa6b1b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19764811" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_44aa6afedcb89ee63968465c4eaa6b1b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_750eda7091ee57e3909d4c49d12ee831">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CK2A1</bp:displayName>
 <bp:entityReference rdf:resource="http://identifiers.org/uniprot/P68400" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CK2A1 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_750eda7091ee57e3909d4c49d12ee831</bp:comment>
</bp:Protein>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16095576">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2005</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16095576</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of the tau protein sequence 199-205 in the hippocampal CA3 region of Syrian hamsters in adulthood and during aging.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=6873</bp:url>
</bp:PublicationXref>

<bp:Catalysis rdf:about="http://pathwaycommons.org/pc12/Catalysis_1f2b26b84b8bedc2698a5fd1f10cf72f">
 <bp:controller rdf:resource="http://pathwaycommons.org/pc12/Protein_750eda7091ee57e3909d4c49d12ee831" />
 <bp:controlled rdf:resource="http://pathwaycommons.org/pc12/BiochemicalReaction_d321dff65d9765c70c89de03a6984dd1" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Catalysis_1f2b26b84b8bedc2698a5fd1f10cf72f</bp:comment>
</bp:Catalysis>

<bp:ProteinReference rdf:about="http://identifiers.org/uniprot/P17612">
 <bp:standardName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">cAMP-dependent protein kinase catalytic subunit alpha</bp:standardName>
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P17612" />
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_PRKACA_identity" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KAPCA_HUMAN</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2.7.11.11</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKACA</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA C-alpha</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKACA</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://www.phosphosite.org/phosphosite.owl#po_637</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">KAPCA_HUMAN Reviewed; 351 AA.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://www.phosphosite.org/phosphosite.owl#po_23353</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FUNCTION: Phosphorylates a large number of substrates in thecytoplasm and the nucleus. Regulates the abundance ofcompartmentalized pools of its regulatory subunits throughphosphorylation of PJA2 which binds and ubiquitinates thesesubunits, leading to their subsequent proteolysis. PhosphorylatesCDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA and VASP.RORA is activated by phosphorylation. Required for glucose-mediated adipogenic differentiation increase and osteogenicdifferentiation inhibition from osteoblasts. Involved in theregulation of platelets in response to thrombin and collagen;maintains circulating platelets in a resting state byphosphorylating proteins in numerous platelet inhibitory pathwayswhen in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexesand free active PRKACA stimulates platelets and leads to plateletaggregation by phosphorylating VASP. Prevents theantiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated.RYR2 channel activity is potentiated by phosphorylation inpresence of luminal Ca(2+), leading to reduced amplitude andincreased frequency of store overload-induced Ca(2+) release(SOICR) characterized by an increased rate of Ca(2+) release andpropagation velocity of spontaneous Ca(2+) waves, despite reducedwave amplitude and resting cytosolic Ca(2+). PSMC5/RPT6 activationby phosphorylation stimulates proteasome. Negatively regulatestight junctions (TJs) in ovarian cancer cells via CLDN3phosphorylation. NFKB1 phosphorylation promotes NF-kappa-B p50-p50DNA binding. Involved in embryonic development by down-regulatingthe Hedgehog (Hh) signaling pathway that determines embryo patternformation and morphogenesis. Prevents meiosis resumption inprophase-arrested oocytes via CDC25B inactivation byphosphorylation. May also regulate rapid eye movement (REM) sleepin the pedunculopontine tegmental (PPT). Phosphorylates APOBEC3Gand AICDA. Isoform 2 phosphorylates and activates ABL1 in spermflagellum to promote spermatozoa capacitation. PhosphorylatesHSF1; this phosphorylation promotes HSF1 nuclear localization andtranscriptional activity upon heat shock (PubMed:21085490).{ECO:0000269|PubMed:15642694, ECO:0000269|PubMed:15905176,ECO:0000269|PubMed:16387847, ECO:0000269|PubMed:17333334,ECO:0000269|PubMed:17565987, ECO:0000269|PubMed:17693412,ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:19949837,ECO:0000269|PubMed:20356841, ECO:0000269|PubMed:21085490,ECO:0000269|PubMed:21423175, ECO:0000269|PubMed:21514275,ECO:0000269|PubMed:21812984}.CATALYTIC ACTIVITY:Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999,ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216;EC=2.7.11.11;CATALYTIC ACTIVITY:Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;EC=2.7.11.11;ACTIVITY REGULATION: Allosterically activated by variouscompounds, including ATP. Activated by cAMP; the nucleotide actsas a dynamic and allosteric activator by coupling the two lobes ofapo PKA, enhancing the enzyme dynamics synchronously and primingit for catalysis. Inhibited by H89 (N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide), spiroindoline,azole-based inhibitors, (3s)-amino-aminomethylbenzamide analogs,ARC-1032 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-carbamoylbutyl]hexanamide), ARC-1034 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]hexanamide), ARC-582, ARC-902 (Adc-6-aminohexanoic acid-(D-Arg)(6)-NH(2)), ARC-1012 ((2R)-6-amino-2-(6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}hexanamido)-N-(5-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}pentyl)hexanamide) andARC-1039 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-1-[(5-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}pentyl)carbamoyl]ethyl]hexanamide). {ECO:0000269|PubMed:17909264,ECO:0000269|PubMed:18178622, ECO:0000269|PubMed:19949837,ECO:0000269|PubMed:20137943, ECO:0000269|PubMed:20481595,ECO:0000269|PubMed:20732331}.SUBUNIT: A number of inactive tetrameric holoenzymes are producedby the combination of homo- or heterodimers of the differentregulatory subunits associated with two catalytic subunits. cAMPcauses the dissociation of the inactive holoenzyme into a dimer ofregulatory subunits bound to four cAMP and two free monomericcatalytic subunits. The cAMP-dependent protein kinase catalyticsubunit binds PJA2. Both isoforms 1 and 2 forms activate cAMP-sensitive PKAI and PKAII holoenzymes by interacting withregulatory subunit (R) of PKA, PRKAR1A/PKR1 and PRKAR2A/PKR2,respectively. Interacts with NFKB1, NFKB2 and NFKBIA in platelets;these interactions are disrupted by thrombin and collagen. Bindsto ABL1 in spermatozoa and with CDC25B in oocytes. Interacts withAPOBEC3G and AICDA. Interacts with RAB13; downstream effector ofRAB13 involved in tight junction assembly. Found in a complex atleast composed of MROH2B, PRKACA isoform 2 and TCP11 (Bysimilarity). Interacts with MROH2B (By similarity). Isoform 2interacts with TCP11 (By similarity). Interacts with HSF1(PubMed:21085490). {ECO:0000250|UniProtKB:P05132,ECO:0000269|PubMed:15096524, ECO:0000269|PubMed:16387847,ECO:0000269|PubMed:18836454, ECO:0000269|PubMed:20356841,ECO:0000269|PubMed:20732331, ECO:0000269|PubMed:21085490,ECO:0000269|PubMed:21774789, ECO:0000269|PubMed:21812984}.SUBCELLULAR LOCATION: Cytoplasm. Cell membrane. Nucleus{ECO:0000250}. Mitochondrion {ECO:0000250}. Membrane{ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Translocates intothe nucleus (monomeric catalytic subunit). The inactive holoenzymeis found in the cytoplasm. Distributed throughout the cytoplasm inmeiotically incompetent oocytes. Associated to mitochondrion asmeiotic competence is acquired. Aggregates around the germinalvesicles (GV) at the immature GV stage oocytes (By similarity).Colocalizes with HSF1 in nuclear stress bodies (nSBs) upon heatshock (PubMed:21085490). {ECO:0000250,ECO:0000269|PubMed:21085490}.SUBCELLULAR LOCATION: Isoform 2: Cell projection, cilium,flagellum {ECO:0000269|PubMed:10906071}. Cytoplasmic vesicle,secretory vesicle, acrosome {ECO:0000250|UniProtKB:P05132}.Note=Expressed in the midpiece region of the sperm flagellum(PubMed:10906071). Colocalizes with MROH2B and TCP11 on theacrosome and tail regions in round spermatids and spermatozoaregardless of the capacitation status of the sperm (Bysimilarity). {ECO:0000250|UniProtKB:P05132,ECO:0000269|PubMed:10906071}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1; Synonyms=C-alpha-1;IsoId=P17612-1; Sequence=Displayed;Name=2; Synonyms=C-alpha-2, C-alpha-S, C(s);IsoId=P17612-2; Sequence=VSP_004759;TISSUE SPECIFICITY: Isoform 1 is ubiquitous. Isoform 2 is sperm-specific and is enriched in pachytene spermatocytes but is notdetected in round spermatids. {ECO:0000269|PubMed:10906071,ECO:0000269|PubMed:21812984}.PTM: Asn-3 is partially deaminated to Asp giving rise to 2 majorisoelectric variants, called CB and CA respectively.{ECO:0000250}.PTM: Autophosphorylated. Phosphorylation is enhanced by vitaminK(2). Phosphorylated on threonine and serine residues.Phosphorylation on Thr-198 is required for full activity.{ECO:0000269|PubMed:12372837, ECO:0000269|PubMed:16765046,ECO:0000269|PubMed:17909264, ECO:0000269|PubMed:20137943,ECO:0000269|PubMed:20481595, ECO:0000269|PubMed:20732331,ECO:0000269|PubMed:21774789, ECO:0000269|Ref.41}.PTM: Phosphorylated at Tyr-331 by activated receptor tyrosinekinases EGFR and PDGFR; this increases catalytic efficiency.{ECO:0000250}.DISEASE: Primary pigmented nodular adrenocortical disease 4(PPNAD4) [MIM:615830]: A rare bilateral adrenal defect causingACTH-independent Cushing syndrome. Macroscopic appearance of theadrenals is characteristic with small pigmented micronodulesobserved in the cortex. Adrenal glands show overall normal sizeand weight, and multiple small yellow-to-dark brown nodulessurrounded by a cortex with a uniform appearance. Microscopically,there are moderate diffuse cortical hyperplasia with mostlynonpigmented nodules, multiple capsular deficits and massivecircumscribed and infiltrating extra-adrenal cortical excrescenceswith micronodules. Clinical manifestations of Cushing syndromeinclude facial and truncal obesity, abdominal striae, muscularweakness, osteoporosis, arterial hypertension, diabetes.{ECO:0000269|PubMed:24571724, ECO:0000269|PubMed:24700472,ECO:0000269|PubMed:24747643, ECO:0000269|PubMed:24855271}.Note=The disease is caused by mutations affecting the generepresented in this entry.SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thrprotein kinase family. cAMP subfamily. {ECO:0000305}.WEB RESOURCE: Name=SeattleSNPs;URL=&quot;http://pga.gs.washington.edu/data/prkaca/&quot;; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License.</bp:comment>
</bp:ProteinReference>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_4119c35f-8fc4-4ee8-864e-ca9b98c057a2http___www_phosphosite_org_phosphosite_owl_recid_4147632">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_4119c35f-8fc4-4ee8-864e-ca9b98c057a2http___www_phosphosite_org_phosphosite_owl_recid_4147632</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3939; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, heart/untreated; &lt;b&gt;Disease:&lt;/b&gt; -; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4147632</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/11401470">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2001</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">11401470</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Identification of Ser(1275) and Ser(1309) as autophosphorylation sites of the human insulin receptor in intact cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=695</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_caba606695d562dc35074da025921972">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_8a835939-5678-4a5f-98d5-21e75085536fhttp___www_phosphosite_org_phosphosite_owl_recid_9392247" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_caba606695d562dc35074da025921972</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/12801934">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2003</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">12801934</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2674</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_605bc3e2989098adea0581f827b9df1a">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INSR</bp:displayName>
 <bp:entityReference rdf:resource="http://identifiers.org/uniprot/P06213" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INSR (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_605bc3e2989098adea0581f827b9df1a</bp:comment>
</bp:Protein>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/12387894">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2002</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">12387894</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=1300</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_90bf205d59d781c725fe08adcb93f27c">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FANCE</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FANCE (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_90bf205d59d781c725fe08adcb93f27c</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_df29491dfd113a860fef5b383ed96af5">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_dca25ce4-4e0a-4792-9542-1c7bcf6178d6http___www_phosphosite_org_phosphosite_owl_recid_3360252" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_df29491dfd113a860fef5b383ed96af5</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24117733">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2014</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24117733</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=40813001</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_953b46c6ae2bcc66dc85cc131625c4fa">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">profilin 1</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">profilin 1 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_953b46c6ae2bcc66dc85cc131625c4fa</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_5f71343bed65546f2bc40bc0e9812418">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21406692" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_5f71343bed65546f2bc40bc0e9812418</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:BiochemicalReaction rdf:about="http://pathwaycommons.org/pc12/BiochemicalReaction_8902805f00df6b8caa8d76acb6a2476a">
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_c0f6d4844421f3fd063c91830de6fb92" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_c74a68196d56fbfbe6197213c6bec416" />
 <bp:right rdf:resource="http://pathwaycommons.org/pc12/Protein_a8a43e3e64cead6a052cc0eb27e76505" />
 <bp:left rdf:resource="http://pathwaycommons.org/pc12/Protein_5c581dc8fdb520f4d8032a389dbfdc55" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/BiochemicalReaction_8902805f00df6b8caa8d76acb6a2476a</bp:comment>
 <bp:conversionDirection rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEFT_TO_RIGHT</bp:conversionDirection>
</bp:BiochemicalReaction>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_b570d62f-eb36-4588-8d4b-ac4127f8982dhttp___www_phosphosite_org_phosphosite_owl_recid_3359308">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_b570d62f-eb36-4588-8d4b-ac4127f8982dhttp___www_phosphosite_org_phosphosite_owl_recid_3359308</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3348; &lt;b&gt;Year:&lt;/b&gt; 2007; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, colon/untreated; &lt;b&gt;Disease:&lt;/b&gt; colorectal cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359308</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20164059">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20164059</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=12736401</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_9fbe7f0c-6610-4bee-b3b9-a671312b1d24http___www_phosphosite_org_phosphosite_owl_recid_9390598">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_9fbe7f0c-6610-4bee-b3b9-a671312b1d24http___www_phosphosite_org_phosphosite_owl_recid_9390598</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 6541; &lt;b&gt;Year:&lt;/b&gt; 2009; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, Jurkat/untreated; &lt;b&gt;Disease:&lt;/b&gt; T cell leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-(Ser/Thr) PKD Substrate Antibody Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=4381&gt;4381&lt;/a&gt;, PTMScan(R) Phospho-PKD Substrate Motif (LXRXXpS/pT) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1986&gt;1986&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9390598</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_c61a88e28c312d7fccd0871aa610b1d2">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20466736" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_c61a88e28c312d7fccd0871aa610b1d2</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/27281782">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2016</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">27281782</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Simultaneous Enrichment of Cysteine-containing Peptides and Phosphopeptides Using a Cysteine-specific Phosphonate Adaptable Tag (CysPAT) in Combination with titanium dioxide (TiO2) Chromatography.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=56552558</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_58dcd99ef985a3117f2a4ad1cb0c2b28">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24670416" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_58dcd99ef985a3117f2a4ad1cb0c2b28</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_7a61102de68f980493fe1b0fb00e7c2c">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/10090741" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_7a61102de68f980493fe1b0fb00e7c2c</bp:comment>
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_c7a5e4aa-1351-4d4c-99a4-233c6d0b0aa6http___www_phosphosite_org_phosphosite_owl_recid_4148186">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_c7a5e4aa-1351-4d4c-99a4-233c6d0b0aa6http___www_phosphosite_org_phosphosite_owl_recid_4148186</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3332; &lt;b&gt;Year:&lt;/b&gt; 2007; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, thyroid/untreated; &lt;b&gt;Disease:&lt;/b&gt; thyroid cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4148186</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_d4652ab42e87a5066f4067765d58c52e">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19413330" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_d4652ab42e87a5066f4067765d58c52e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/17008320">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2006</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">17008320</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Removal of pattern-breaking sequences in microtubule binding repeats produces instantaneous tau aggregation and toxicity.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2653900</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21653224">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21653224</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Effect of exercise and training on phospholemman phosphorylation in human skeletal muscle.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=21386607</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a5d456dba60b50168f2cb429c9fac047">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20166139" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a5d456dba60b50168f2cb429c9fac047</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/19764811">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19764811</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">In vivo phosphoproteome of human skeletal muscle revealed by phosphopeptide enrichment and HPLC-ESI-MS/MS.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9933805</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_8db79d3819878fce1b849711ae6ab24f">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/26161867" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_8db79d3819878fce1b849711ae6ab24f</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Catalysis rdf:about="http://pathwaycommons.org/pc12/Catalysis_6cc2228858bfe4dbcb8710e2219f957f">
 <bp:controller rdf:resource="http://pathwaycommons.org/pc12/Protein_d8a8eba80f0605e86aaa096c4c3961eb" />
 <bp:controlled rdf:resource="http://pathwaycommons.org/pc12/BiochemicalReaction_8902805f00df6b8caa8d76acb6a2476a" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Catalysis_6cc2228858bfe4dbcb8710e2219f957f</bp:comment>
</bp:Catalysis>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/17078951">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2006</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">17078951</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2587207</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_2fdb180bce7664cb00e7beeb26d72a03">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20363803" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_2fdb180bce7664cb00e7beeb26d72a03</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Catalysis rdf:about="http://pathwaycommons.org/pc12/Catalysis_e0a295c377373296715f0a5263f5ee3a">
 <bp:controller rdf:resource="http://pathwaycommons.org/pc12/Protein_cb3c7b2020d3b37ac72775d896168e70" />
 <bp:controlled rdf:resource="http://pathwaycommons.org/pc12/BiochemicalReaction_9d1305df603e0573d0497b2c2e5c247f" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Catalysis_e0a295c377373296715f0a5263f5ee3a</bp:comment>
</bp:Catalysis>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_5afaeff163cb9582329948fde4fabf63">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24113872" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_5afaeff163cb9582329948fde4fabf63</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_e796264d30864011f6530b8b64c01394">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/29950669" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_e796264d30864011f6530b8b64c01394</bp:comment>
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21957166">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21957166</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protein kinase CÎ± activity is important for contraction-induced FXYD1 phosphorylation in skeletal muscle.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=21386603</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_f2993f211d95a7820505fe5e4daf85c3">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tyk2</bp:displayName>
 <bp:entityReference rdf:resource="http://identifiers.org/uniprot/P29597" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tyk2 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_f2993f211d95a7820505fe5e4daf85c3</bp:comment>
</bp:Protein>

<bp:EvidenceCodeVocabulary rdf:about="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_molecular_interactions_ontology_MI_0421" />
 <bp:term rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">identification by antibody</bp:term>
</bp:EvidenceCodeVocabulary>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/15664690">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2005</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">15664690</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4420</bp:url>
</bp:PublicationXref>

<bp:Catalysis rdf:about="http://pathwaycommons.org/pc12/Catalysis_0d6377e9e148f7bf2b40d877718e00eb">
 <bp:controller rdf:resource="http://pathwaycommons.org/pc12/Protein_f2993f211d95a7820505fe5e4daf85c3" />
 <bp:controlled rdf:resource="http://pathwaycommons.org/pc12/BiochemicalReaction_89e4c2427e3567bffcc52498b643e2ee" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Catalysis_0d6377e9e148f7bf2b40d877718e00eb</bp:comment>
</bp:Catalysis>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24075978">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24075978</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=29642423</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/26429909">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2015</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26429909</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Molecular Mechanisms and Kinetic Effects of FXYD1 and Phosphomimetic Mutants on Purified Human Na,K-ATPase.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=50522805</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/10090741">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">1999</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">10090741</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=10303912</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/9614189">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">1998</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">9614189</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer&apos;s disease.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=1299</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_0f5319a1afb2dec59ad78fc7f643eb27">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24275569" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_0f5319a1afb2dec59ad78fc7f643eb27</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_d966642df0d0f7db156760914f92c78a">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21367866" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_d966642df0d0f7db156760914f92c78a</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_7e029d08f164a1ee562ee2b294867ce8">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_4032b3c8-22be-4932-9abe-7b76e886ef76http___www_phosphosite_org_phosphosite_owl_recid_3359224" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_7e029d08f164a1ee562ee2b294867ce8</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_52854541d201d434b7025ba3098b246b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/27251275" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_52854541d201d434b7025ba3098b246b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/17971449">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">17971449</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3 -dependent phosphorylation of Tau.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3394309</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f65e294c40c4fcb2f91465410805113e">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15973541" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f65e294c40c4fcb2f91465410805113e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20166139">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20166139</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=13974105</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_852fd9862a2f30f4d914c87b270fe37f">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_f811415c-b835-440f-a939-b3d7df86e18ahttp___www_phosphosite_org_phosphosite_owl_recid_3358468" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_852fd9862a2f30f4d914c87b270fe37f</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_c0f6d4844421f3fd063c91830de6fb92">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21918188" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_c0f6d4844421f3fd063c91830de6fb92</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:Catalysis rdf:about="http://pathwaycommons.org/pc12/Catalysis_9d992ec9ed18884480bfa5da6c0d213f">
 <bp:controller rdf:resource="http://pathwaycommons.org/pc12/Protein_cabd1e2e223e7c67ec14cf7bd044dfd1" />
 <bp:controlled rdf:resource="http://pathwaycommons.org/pc12/BiochemicalReaction_a8bd9ac135676a62b0f0fb840c36ecd9" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Catalysis_9d992ec9ed18884480bfa5da6c0d213f</bp:comment>
</bp:Catalysis>

<bp:Catalysis rdf:about="http://pathwaycommons.org/pc12/Catalysis_04641c47b7942f444c0afd30b1eaa305">
 <bp:controller rdf:resource="http://pathwaycommons.org/pc12/Protein_605bc3e2989098adea0581f827b9df1a" />
 <bp:controlled rdf:resource="http://pathwaycommons.org/pc12/BiochemicalReaction_a35d892c9b16f11053b958a2cf7e899c" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Catalysis_04641c47b7942f444c0afd30b1eaa305</bp:comment>
</bp:Catalysis>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_7322734616e09c711d18f28538e4fa1a">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_0a667d8b-ff67-40cd-94dc-b0967b78941ehttp___www_phosphosite_org_phosphosite_owl_recid_9391666" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_7322734616e09c711d18f28538e4fa1a</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Catalysis rdf:about="http://pathwaycommons.org/pc12/Catalysis_5871e595962b6bb0cc8e73405cae5eae">
 <bp:controller rdf:resource="http://pathwaycommons.org/pc12/Protein_bd5959a4447d8409414a368dac8f4482" />
 <bp:controlled rdf:resource="http://pathwaycommons.org/pc12/BiochemicalReaction_b75dabc8c32709e0ad4cb70a73737504" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Catalysis_5871e595962b6bb0cc8e73405cae5eae</bp:comment>
</bp:Catalysis>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_e0b9f6b1e7c2962a26c501a826755cc5">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/9832145" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_e0b9f6b1e7c2962a26c501a826755cc5</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_bc76ad2d2f4075922ff2cd3f9313e857">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">smMLCK</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">smMLCK (rabbit)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_bc76ad2d2f4075922ff2cd3f9313e857</bp:comment>
</bp:Protein>

<bp:BiochemicalReaction rdf:about="http://pathwaycommons.org/pc12/BiochemicalReaction_89e4c2427e3567bffcc52498b643e2ee">
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_482f30f2e0cc9270d2a21e8b31eb470c" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_caba606695d562dc35074da025921972" />
 <bp:right rdf:resource="http://pathwaycommons.org/pc12/Protein_afb96caa0c496efae8ce4175ed60f927" />
 <bp:left rdf:resource="http://pathwaycommons.org/pc12/Protein_bd59c7f51b17e222ae2ed81d71e5d768" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/BiochemicalReaction_89e4c2427e3567bffcc52498b643e2ee</bp:comment>
 <bp:conversionDirection rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEFT_TO_RIGHT</bp:conversionDirection>
</bp:BiochemicalReaction>

<bp:Catalysis rdf:about="http://pathwaycommons.org/pc12/Catalysis_ede2cf6881735a7916a66222a463d484">
 <bp:controller rdf:resource="http://pathwaycommons.org/pc12/Protein_4e2f42732e1a51ae8a54fd2e95080899" />
 <bp:controlled rdf:resource="http://pathwaycommons.org/pc12/BiochemicalReaction_899fcce638d0b58bd8a85acaae7826d8" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Catalysis_ede2cf6881735a7916a66222a463d484</bp:comment>
</bp:Catalysis>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_42e3d74e-8f5f-4b7a-a4a7-8c00676da34chttp___www_phosphosite_org_phosphosite_owl_recid_3359110">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_42e3d74e-8f5f-4b7a-a4a7-8c00676da34chttp___www_phosphosite_org_phosphosite_owl_recid_3359110</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4119; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, gastrointestinal tract/untreated; &lt;b&gt;Disease:&lt;/b&gt; gastric carcinoma; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359110</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_c2706846347e967b9a281d92483a3a6e">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_144447d5-966b-447c-8e5d-7d45f90b9ef7http___www_phosphosite_org_phosphosite_owl_recid_3360122" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_c2706846347e967b9a281d92483a3a6e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f90c7682e3b758813245d9de8ea0ccd0">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/28814543" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f90c7682e3b758813245d9de8ea0ccd0</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_78f6d45c-29d9-404a-a127-3f74b25b485ahttp___www_phosphosite_org_phosphosite_owl_recid_3360280">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_78f6d45c-29d9-404a-a127-3f74b25b485ahttp___www_phosphosite_org_phosphosite_owl_recid_3360280</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3911; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, liver/untreated; &lt;b&gt;Disease:&lt;/b&gt; liver cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3360280</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/11104762">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2001</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">11104762</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of tau is regulated by PKN.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2763</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_cabd1e2e223e7c67ec14cf7bd044dfd1">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKACA</bp:displayName>
 <bp:entityReference rdf:resource="http://identifiers.org/uniprot/P17612" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PKACA (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_cabd1e2e223e7c67ec14cf7bd044dfd1</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_6705788ddac21dcdc0db2f59f1564d0c">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16787414" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_6705788ddac21dcdc0db2f59f1564d0c</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_30069b411a8d5b13074368a0459a172f">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24719451" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_30069b411a8d5b13074368a0459a172f</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_4b64dd74821979a18e0c00b30cf92149">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/23428800" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_4b64dd74821979a18e0c00b30cf92149</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_cead2e4a445aa86c9489817d17bcb07e">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/12765608" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_cead2e4a445aa86c9489817d17bcb07e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a1544d8dda29f8484501418777147bea">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_0a2eb0ec-7b2a-4b19-9831-c428cd2a2577http___www_phosphosite_org_phosphosite_owl_recid_3359098" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a1544d8dda29f8484501418777147bea</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/17562708">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">17562708</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=12258</bp:url>
</bp:PublicationXref>

<bp:BiochemicalReaction rdf:about="http://pathwaycommons.org/pc12/BiochemicalReaction_b75dabc8c32709e0ad4cb70a73737504">
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_dbe2f4d85d5d9e01fa2b3e2e13f28161" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_d4652ab42e87a5066f4067765d58c52e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_fa67ff56711e8a7971f0112e76afe538" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_0a44b539d7044a2ed6a044d69aaa2e50" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_2fdb180bce7664cb00e7beeb26d72a03" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f65586e57b3d23377c0a31d6f447d980" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_e88abcd22777005ddef6184a9a8d19de" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_478a79c626618753ab82c775e4550701" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_7627a9518f8d3392d513fb52c6bda5ea" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_8b10cb82ff11ca12afbc90ac476bd73b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_78f83f3ac869808dce673b9edbc54aaa" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f0c4a68a47dc4fac3dcc4406a7230b46" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_7840c5c5dec9a331abd4cf0aa666d829" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_5dc2eaaa35893a7862d9d3bafa4a6cb9" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_466cc634adfa3e7dfdd2c73fc0518547" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_c41d3b53dd13fc65aa167ba1342ab94b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_bf828332b2dbe1382949fe4abc4f6493" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_0b48435062bd1bc4a500489eaaf0ac00" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_9dcd784c741dde00c09acebed3007276" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_20b60462ccc360253434dbe5c5200f64" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_0f5319a1afb2dec59ad78fc7f643eb27" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_9bf3355ac093a31615016f22f62e3a20" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_df772a98f300a640b54217eaa50b458d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_52854541d201d434b7025ba3098b246b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_b9856974a50645815a89ea8f1db19032" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_7f6e5b75cc5707ce38a7e95982eba4f6" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_bbc2b506ec9c925b070c24fb57eda29d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a936b097697035b5053d4dc4f60d3f07" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f6a55c82bfcd9a4cba93dcf7d7b592ab" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_3e09600ac36144e9af27966ea971df25" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_cb02e73fd41a45de7730c43043dec9e7" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_372549b5cc6447eccd6da83f90ffcdcb" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_7322734616e09c711d18f28538e4fa1a" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_cb98d8eb5cde4fbfb39e6fbd9eeebe4e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_051dbd245451fdf9caa719c11430f9ea" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_ef8361a83e8b2c8132a30d73fc56d7ab" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_80d7af68be4af035afe706bbac60ea92" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_c2706846347e967b9a281d92483a3a6e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_807e70318d4f2ea94e51536dd09b0506" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_8d94f11e0727e27b58beaeb6a8004855" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_078a9710606b83029ad8545edc745a83" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_6ed22b3b8266351534058ae6dec3df13" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_6a168c4c29a3eb9f12a41778c8ecf44d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_30069b411a8d5b13074368a0459a172f" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_fb25f5b2a4b8cb40cea2f3f66b32e7e4" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_52050da2c1534808e290c3969c99110b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_9e8c0dcd30294671702f0bd1e9cc44a5" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_212abeea6ef6bf72d0d5f18f95381e20" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_15e5789a3ba6bc29c241b18cf642b814" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_5f71343bed65546f2bc40bc0e9812418" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_bc925e06a06ccad92bea220d16569b9f" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_49bd4922de2801f9ef5fe266097334e3" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_8755f22d841f3dbac268936590a3dc32" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_115088b6bbb0d717231f7f79d0ac758b" />
 <bp:right rdf:resource="http://pathwaycommons.org/pc12/Protein_926fad8c1e8743a5cc93556818caef16" />
 <bp:left rdf:resource="http://pathwaycommons.org/pc12/Protein_da7c4217ace8a8a0da7b00452be634bd" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/BiochemicalReaction_b75dabc8c32709e0ad4cb70a73737504</bp:comment>
 <bp:conversionDirection rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEFT_TO_RIGHT</bp:conversionDirection>
</bp:BiochemicalReaction>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_a5c3e993-bb2b-4a80-91a6-e4696ae14c9ahttp___www_phosphosite_org_phosphosite_owl_recid_3358530">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_a5c3e993-bb2b-4a80-91a6-e4696ae14c9ahttp___www_phosphosite_org_phosphosite_owl_recid_3358530</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3870; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, lung/untreated; &lt;b&gt;Disease:&lt;/b&gt; non-small cell lung cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3358530</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_15e5789a3ba6bc29c241b18cf642b814">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/22547687" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_15e5789a3ba6bc29c241b18cf642b814</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/15973541">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2005</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">15973541</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Individual and regional variations of phospho-tau species in progressive supranuclear palsy.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=6366</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_4015d6ead1188fb14d3f23f45acfd6b6">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20550628" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_4015d6ead1188fb14d3f23f45acfd6b6</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_00ddc0b2d3f3dacd37f4ad0afea3385e">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15190058" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_00ddc0b2d3f3dacd37f4ad0afea3385e</bp:comment>
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_4e2f42732e1a51ae8a54fd2e95080899">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Chk1</bp:displayName>
 <bp:entityReference rdf:resource="http://identifiers.org/uniprot/O14757" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Chk1 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_4e2f42732e1a51ae8a54fd2e95080899</bp:comment>
</bp:Protein>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_da7c4217ace8a8a0da7b00452be634bd">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">H1E</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">H1E (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_da7c4217ace8a8a0da7b00452be634bd</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_76bcdf2ad44c06fcdf0cc8116be550b4">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20159774" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_76bcdf2ad44c06fcdf0cc8116be550b4</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_0a667d8b-ff67-40cd-94dc-b0967b78941ehttp___www_phosphosite_org_phosphosite_owl_recid_9391666">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_0a667d8b-ff67-40cd-94dc-b0967b78941ehttp___www_phosphosite_org_phosphosite_owl_recid_9391666</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 5897; &lt;b&gt;Year:&lt;/b&gt; 2009; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, Jurkat/calyculin_A &amp; pervanadate; &lt;b&gt;Disease:&lt;/b&gt; T cell leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; (K/R)XpSX(K/R)&lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-(Ser) PKC Substrate Antibody Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=2261&gt;2261&lt;/a&gt;, PTMScan(R) Phospho-PKC Substrate Motif (K/RXpSXK/R) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1985&gt;1985&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9391666</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/23628362">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">23628362</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=40813000</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_65174f81df69e5d6b62e4a6a5f9b43ae">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15994305" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_65174f81df69e5d6b62e4a6a5f9b43ae</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/18669648">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">18669648</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A quantitative atlas of mitotic phosphorylation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3090800</bp:url>
</bp:PublicationXref>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P68400">
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRIMARY</bp:comment>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P68400</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">uniprot knowledgebase</bp:db>
</bp:UnificationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f817fdf6201137786d2b4746bd0e39cc">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24312574" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f817fdf6201137786d2b4746bd0e39cc</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_51d1caee-9dac-4c62-92ce-bf769cfd7877http___www_phosphosite_org_phosphosite_owl_recid_3358772">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_51d1caee-9dac-4c62-92ce-bf769cfd7877http___www_phosphosite_org_phosphosite_owl_recid_3358772</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3982; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, pancreas/untreated; &lt;b&gt;Disease:&lt;/b&gt; pancreatic cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3358772</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f157bdb2993dcfe3b4e5f104a88e8ca5">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17078951" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f157bdb2993dcfe3b4e5f104a88e8ca5</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_8b9b2f0f54bcf3e03bf56985edff2b15">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24033439" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_8b9b2f0f54bcf3e03bf56985edff2b15</bp:comment>
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/28758999">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2017</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">28758999</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Necroptosis activation in Alzheimer&apos;s disease.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=460257501</bp:url>
</bp:PublicationXref>

<bp:EvidenceCodeVocabulary rdf:about="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_molecular_interactions_ontology_MI_0113" />
 <bp:term rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">western blot</bp:term>
</bp:EvidenceCodeVocabulary>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/19276368">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19276368</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC25B mediates rapamycin-induced oncogenic responses in cancer cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=6829209</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_53e00bc8ba4523daa2fa4351a3cce8dc">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/26555036" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_53e00bc8ba4523daa2fa4351a3cce8dc</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_047a3d13-e45a-44aa-bfe9-195aaf1ffab7http___www_phosphosite_org_phosphosite_owl_recid_3359080">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_047a3d13-e45a-44aa-bfe9-195aaf1ffab7http___www_phosphosite_org_phosphosite_owl_recid_3359080</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3311; &lt;b&gt;Year:&lt;/b&gt; 2007; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, colon/untreated; &lt;b&gt;Disease:&lt;/b&gt; colorectal cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359080</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_2ca8d6eb-d5dc-420c-9133-4d150673f602http___www_phosphosite_org_phosphosite_owl_recid_3358922">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_2ca8d6eb-d5dc-420c-9133-4d150673f602http___www_phosphosite_org_phosphosite_owl_recid_3358922</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4014; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, gastrointestinal tract/untreated; &lt;b&gt;Disease:&lt;/b&gt; gastric cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3358922</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a3d29057349ab78b1f95116a8db81764">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/12801934" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a3d29057349ab78b1f95116a8db81764</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_556f824a2412518de96baff1e54cf925">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_78f6d45c-29d9-404a-a127-3f74b25b485ahttp___www_phosphosite_org_phosphosite_owl_recid_3360280" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_556f824a2412518de96baff1e54cf925</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/9832145">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">1998</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">9832145</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer&apos;s disease brain using nanoelectrospray mass spectrometry.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=10167117</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_9dcd784c741dde00c09acebed3007276">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/26506913" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_9dcd784c741dde00c09acebed3007276</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_3375e4d822db3246a0a5565981d89f3f">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_2a087c70-081b-42c5-a7fe-fe27d89a8567http___www_phosphosite_org_phosphosite_owl_recid_3360282" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_3375e4d822db3246a0a5565981d89f3f</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_fe87e3a9-a0b6-4f0a-9dc9-871385ebfedehttp___www_phosphosite_org_phosphosite_owl_recid_3360256">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_fe87e3a9-a0b6-4f0a-9dc9-871385ebfedehttp___www_phosphosite_org_phosphosite_owl_recid_3360256</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3909; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, liver/untreated; &lt;b&gt;Disease:&lt;/b&gt; liver cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3360256</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_123cc86844e0284ebfc20a089120c9dd">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/9716264" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_123cc86844e0284ebfc20a089120c9dd</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_ea1b457320fff6f706710b5652d8cb58">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INSR iso2</bp:displayName>
 <bp:entityReference rdf:resource="http://identifiers.org/uniprot/P06213" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INSR iso2 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_ea1b457320fff6f706710b5652d8cb58</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_b41b70000563924cb6c56088443e44ef">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/8506352" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_b41b70000563924cb6c56088443e44ef</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f833d1f60763c902bc71865e050746de">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/9716264" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f833d1f60763c902bc71865e050746de</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_bd5959a4447d8409414a368dac8f4482">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK1</bp:displayName>
 <bp:entityReference rdf:resource="http://identifiers.org/uniprot/P06493" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK1 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_bd5959a4447d8409414a368dac8f4482</bp:comment>
</bp:Protein>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/9716264">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">1998</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">9716264</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer&apos;s disease.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2855</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_bbbadc6a88bcc5942d61cbe25684dee6">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/12387894" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_bbbadc6a88bcc5942d61cbe25684dee6</bp:comment>
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21327254">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21327254</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=18410828</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/26555036">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2015</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26555036</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of a splice variant of collapsin response mediator protein 2 in the nucleus of tumour cells links cyclin dependent kinase-5 to oncogenesis.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=50875756</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_c1c595c4-aeb8-4655-af44-1eb93165dc77http___www_phosphosite_org_phosphosite_owl_recid_3360074">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_c1c595c4-aeb8-4655-af44-1eb93165dc77http___www_phosphosite_org_phosphosite_owl_recid_3360074</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4389; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, K562/untreated; &lt;b&gt;Disease:&lt;/b&gt; chronic myelogenous leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; p[STY])</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3360074</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_1a5bd2f6f72b401a7667a7b60f384792">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/9832145" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_1a5bd2f6f72b401a7667a7b60f384792</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_89009127-7add-4299-8d8b-17601de57d05http___www_phosphosite_org_phosphosite_owl_recid_3359104">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_89009127-7add-4299-8d8b-17601de57d05http___www_phosphosite_org_phosphosite_owl_recid_3359104</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4118; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, gastrointestinal tract/untreated; &lt;b&gt;Disease:&lt;/b&gt; gastric carcinoma; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359104</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/18725412">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">18725412</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=6115906</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_af48b4cf2e2cef2368a160c396aafc88">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15973541" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_af48b4cf2e2cef2368a160c396aafc88</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/23186163">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">23186163</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Toward a comprehensive characterization of a human cancer cell phosphoproteome.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=28701802</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_be4d52bf63a0103ee44c523d8ae3c06a">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/22942356" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_be4d52bf63a0103ee44c523d8ae3c06a</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_6ed22b3b8266351534058ae6dec3df13">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17924679" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_6ed22b3b8266351534058ae6dec3df13</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_3a420741-3aab-499f-821f-f8656ffb62fchttp___www_phosphosite_org_phosphosite_owl_recid_3359322">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_3a420741-3aab-499f-821f-f8656ffb62fchttp___www_phosphosite_org_phosphosite_owl_recid_3359322</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4153; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, lung/untreated; &lt;b&gt;Disease:&lt;/b&gt; non-small cell lung cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359322</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/26506913">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2015</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26506913</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Combined Analyses of the VHL and Hypoxia Signaling Axes in an Isogenic Pairing of Renal Clear Cell Carcinoma Cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=50582502</bp:url>
</bp:PublicationXref>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P06493">
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRIMARY</bp:comment>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P06493</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">uniprot knowledgebase</bp:db>
</bp:UnificationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_fb25f5b2a4b8cb40cea2f3f66b32e7e4">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20815410" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_fb25f5b2a4b8cb40cea2f3f66b32e7e4</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/9556631">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">1998</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">9556631</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. Synergism with cyclic nucleotide-activated kinase.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=8974</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_cb3c7b2020d3b37ac72775d896168e70">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK1</bp:displayName>
 <bp:entityReference rdf:resource="http://identifiers.org/uniprot/Q13464" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK1 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_cb3c7b2020d3b37ac72775d896168e70</bp:comment>
</bp:Protein>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/19451179">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19451179</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer&apos;s disease.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=8165400</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_9a37d2df-3978-4a66-8ef8-d8e4ae4e5999http___www_phosphosite_org_phosphosite_owl_recid_9391600">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_9a37d2df-3978-4a66-8ef8-d8e4ae4e5999http___www_phosphosite_org_phosphosite_owl_recid_9391600</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 6239; &lt;b&gt;Year:&lt;/b&gt; 2009; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, HeLa/nocodazole; &lt;b&gt;Disease:&lt;/b&gt; cervical adenocarcinoma; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; (K/R)XpSX(K/R)&lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-(Ser) PKC Substrate Antibody Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=2261&gt;2261&lt;/a&gt;, PTMScan(R) Phospho-PKC Substrate Motif (K/RXpSXK/R) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1985&gt;1985&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9391600</bp:url>
</bp:PublicationXref>

<bp:ProteinReference rdf:about="http://identifiers.org/uniprot/Q13464">
 <bp:standardName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rho-associated protein kinase 1</bp:standardName>
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_ROCK1_identity" />
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_Q13464" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK1_HUMAN</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rho-associated, coiled-coil-containing protein kinase I</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p160ROCK</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2.7.11.1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK-I</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Rho-associated, coiled-coil-containing protein kinase 1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p160 ROCK-1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Renal carcinoma antigen NY-REN-35</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK1_HUMAN Reviewed; 1354 AA.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://www.phosphosite.org/phosphosite.owl#po_754</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FUNCTION: Protein kinase which is a key regulator of actincytoskeleton and cell polarity. Involved in regulation of smoothmuscle contraction, actin cytoskeleton organization, stress fiberand focal adhesion formation, neurite retraction, cell adhesionand motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2,MYL9/MLC2, PFN1 and PPP1R12A. Phosphorylates FHOD1 and actssynergistically with it to promote SRC-dependent non-apoptoticplasma membrane blebbing. Phosphorylates JIP3 and regulates therecruitment of JNK to JIP3 upon UVB-induced stress. Acts as asuppressor of inflammatory cell migration by regulating PTENphosphorylation and stability. Acts as a negative regulator ofVEGF-induced angiogenic endothelial cell activation. Required forcentrosome positioning and centrosome-dependent exit from mitosis.Plays a role in terminal erythroid differentiation. May regulateclosure of the eyelids and ventral body wall by inducing theassembly of actomyosin bundles. Promotes keratinocyte terminaldifferentiation. Involved in osteoblast compaction through thefibronectin fibrillogenesis cell-mediated matrix assembly process,essential for osteoblast mineralization.{ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:10652353,ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:11283607,ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:18573880,ECO:0000269|PubMed:18694941, ECO:0000269|PubMed:19036714,ECO:0000269|PubMed:19131646, ECO:0000269|PubMed:19181962,ECO:0000269|PubMed:19997641, ECO:0000269|PubMed:21072057,ECO:0000269|PubMed:8617235, ECO:0000269|PubMed:9722579}.CATALYTIC ACTIVITY:Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999,ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216;EC=2.7.11.1;CATALYTIC ACTIVITY:Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;EC=2.7.11.1;COFACTOR:Name=Mg(2+); Xref=ChEBI:CHEBI:18420;ACTIVITY REGULATION: Activated by RHOA binding. Inhibited by Y-27632.SUBUNIT: Homodimer. Interacts with RHOB, RHOC, MYLC2B and PTEN.Interacts with ITGB1BP1 (via N-terminus and PTB domain) (Bysimilarity). Interacts with RHOA (activated by GTP), CHORDC1,DAPK3, GEM, JIP3, RHOE, PPP1R12A, PFN1, LIMK1, LIMK2 and TSG101.Interacts with FHOD1 in a Src-dependent manner. {ECO:0000250,ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:10652353,ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:11283607,ECO:0000269|PubMed:11956230, ECO:0000269|PubMed:12773565,ECO:0000269|PubMed:14660612, ECO:0000269|PubMed:16249185,ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:17853893,ECO:0000269|PubMed:18573880, ECO:0000269|PubMed:18694941,ECO:0000269|PubMed:19036714, ECO:0000269|PubMed:19131646,ECO:0000269|PubMed:20230755, ECO:0000269|PubMed:8617235}.SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton,microtubule organizing center, centrosome, centriole{ECO:0000250}. Golgi apparatus membrane; Peripheral membraneprotein. Cell projection, bleb. Cytoplasm, cytoskeleton{ECO:0000250}. Cell membrane {ECO:0000250}. Cell projection,lamellipodium {ECO:0000250}. Cell projection, ruffle{ECO:0000250}. Note=Associated with the mother centriole and anintercentriolar linker. Colocalizes with ITGB1BP1 and ITGB1 at thecell membrane predominantly in lamellipodia and membrane ruffles,but also in retraction fibers. Localizes at the cell membrane inan ITGB1BP1-dependent manner (By similarity). A small proportionis associated with Golgi membranes. {ECO:0000250}.TISSUE SPECIFICITY: Detected in blood platelets.{ECO:0000269|PubMed:8617235}.DOMAIN: The C-terminal auto-inhibitory domain interferes withkinase activity. RHOA binding leads to a conformation change andactivation of the kinase. Truncated ROCK1 is constitutivelyactivated.PTM: Autophosphorylated on serine and threonine residues.{ECO:0000269|PubMed:8617235}.PTM: Cleaved by caspase-3 during apoptosis. This leads toconstitutive activation of the kinase and membrane blebbing.SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thrprotein kinase family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License.</bp:comment>
</bp:ProteinReference>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/23428800">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">23428800</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PTPA activates protein phosphatase-2A through reducing its phosphorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=28077705</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/18052981">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">18052981</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3475711</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/15994305">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2005</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">15994305</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=5955612</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_91a161fcb3c2923035f04624d7537aa7">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_4119c35f-8fc4-4ee8-864e-ca9b98c057a2http___www_phosphosite_org_phosphosite_owl_recid_4147632" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_91a161fcb3c2923035f04624d7537aa7</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_bec7c74b7a5fab8cf217525cea53450d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18573880" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_bec7c74b7a5fab8cf217525cea53450d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:RelationshipXref rdf:about="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_ROCK1_identity">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">ROCK1</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hgnc symbol</bp:db>
</bp:RelationshipXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20833797">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20833797</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=15562537</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_bc2db127a925dfb50367579c423d601a">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24301651" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_bc2db127a925dfb50367579c423d601a</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21659605">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21659605</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=19044701</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21659604">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21659604</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=19044700</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/10636877">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2000</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">10636877</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Architecture of high mobility group protein I-C.DNA complex and its perturbation upon phosphorylation by Cdc2 kinase.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=10292901</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20308788">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20308788</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=12728103</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_137ed609724abfb63003f9aa8592e6c7">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/23684622" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_137ed609724abfb63003f9aa8592e6c7</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_9f02d61aa39e1c57a2407d662de5d01a">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_42e3d74e-8f5f-4b7a-a4a7-8c00676da34chttp___www_phosphosite_org_phosphosite_owl_recid_3359110" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_9f02d61aa39e1c57a2407d662de5d01a</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_Q13464">
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRIMARY</bp:comment>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Q13464</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">uniprot knowledgebase</bp:db>
</bp:UnificationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a3122615ffa6ce441570856de4a7d87f">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_943e7eb1-da6d-4436-b484-a5271468b485http___www_phosphosite_org_phosphosite_owl_recid_3359210" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a3122615ffa6ce441570856de4a7d87f</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_7840c5c5dec9a331abd4cf0aa666d829">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_a2712524-cd1b-40c7-96d0-220e66cd332ehttp___www_phosphosite_org_phosphosite_owl_recid_4918532" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_7840c5c5dec9a331abd4cf0aa666d829</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_144447d5-966b-447c-8e5d-7d45f90b9ef7http___www_phosphosite_org_phosphosite_owl_recid_3360122">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_144447d5-966b-447c-8e5d-7d45f90b9ef7http___www_phosphosite_org_phosphosite_owl_recid_3360122</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4394; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, K562/untreated; &lt;b&gt;Disease:&lt;/b&gt; chronic myelogenous leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; p[STY])</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3360122</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_bb5e93b4b2f36de7530c46b0ee53f1eb">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21659605" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_bb5e93b4b2f36de7530c46b0ee53f1eb</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_5dc2eaaa35893a7862d9d3bafa4a6cb9">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/23186163" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_5dc2eaaa35893a7862d9d3bafa4a6cb9</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_466cc634adfa3e7dfdd2c73fc0518547">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19651622" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_466cc634adfa3e7dfdd2c73fc0518547</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/23749302">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">23749302</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Integrated proteomic analysis of post-translational modifications by serial enrichment.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=38524707</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20506302">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20506302</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Molecular and cellular events of dopamine D1 receptor-mediated tau phosphorylation in SK-N-MC cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=14821609</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_bd59c7f51b17e222ae2ed81d71e5d768">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GJA1</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GJA1 (rat)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_bd59c7f51b17e222ae2ed81d71e5d768</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_66246f0b28a691f352bac54836e12339">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_89009127-7add-4299-8d8b-17601de57d05http___www_phosphosite_org_phosphosite_owl_recid_3359104" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_66246f0b28a691f352bac54836e12339</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_8c59ddf61ae4f180863177aab7b1c02e">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17906291" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_8c59ddf61ae4f180863177aab7b1c02e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_c869605aaadee75290791c26d2cc9f24">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/25084196" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_c869605aaadee75290791c26d2cc9f24</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_e15a3fab704a5c95a988c52863b4c741">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19659459" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_e15a3fab704a5c95a988c52863b4c741</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/2026614">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">1991</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2026614</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Mutation of the two carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2652</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/18573880">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">18573880</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2831751</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f102777cd633a33cca56e9649a56be56">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17296736" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f102777cd633a33cca56e9649a56be56</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_23f3a687f6bfd8a3c3161c0db19f659a">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20550628" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_23f3a687f6bfd8a3c3161c0db19f659a</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24003220">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24003220</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Evaluation of cancer dependence and druggability of PRP4 kinase using cellular, biochemical, and structural approaches.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=40799103</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24757378">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2014</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24757378</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulatory B Subunits of Protein Phosphatase 2A Are Involved in Site-specific Regulation of Tau Protein Phosphorylation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=33332687</bp:url>
</bp:PublicationXref>

<bp:ProteinReference rdf:about="http://identifiers.org/uniprot/P68400">
 <bp:standardName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Casein kinase II subunit alpha</bp:standardName>
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_CSNK2A1_identity" />
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P68400" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSK21_HUMAN</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSNK2A1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2.7.11.1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CK II alpha</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CK2A1</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://www.phosphosite.org/phosphosite.owl#po_798</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSK21_HUMAN Reviewed; 391 AA.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FUNCTION: Catalytic subunit of a constitutively activeserine/threonine-protein kinase complex that phosphorylates alarge number of substrates containing acidic residues C-terminalto the phosphorylated serine or threonine. Regulates numerouscellular processes, such as cell cycle progression, apoptosis andtranscription, as well as viral infection. May act as a regulatorynode which integrates and coordinates numerous signals leading toan appropriate cellular response. During mitosis, functions as acomponent of the p53/TP53-dependent spindle assembly checkpoint(SAC) that maintains cyclin-B-CDK1 activity and G2 arrest inresponse to spindle damage. Also required for p53/TP53-mediatedapoptosis, phosphorylating &apos;Ser-392&apos; of p53/TP53 following UVirradiation. Can also negatively regulate apoptosis.Phosphorylates the caspases CASP9 and CASP2 and the apoptoticregulator NOL3. Phosphorylation protects CASP9 from cleavage andactivation by CASP8, and inhibits the dimerization of CASP2 andactivation of CASP8. Regulates transcription by directphosphorylation of RNA polymerases I, II, III and IV. Alsophosphorylates and regulates numerous transcription factorsincluding NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX,JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperonesFKBP4 and CDC37, which is essential for chaperone function.Regulates Wnt signaling by phosphorylating CTNNB1 and thetranscription factor LEF1. Acts as an ectokinase thatphosphorylates several extracellular proteins. During viralinfection, phosphorylates various proteins involved in the virallife cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV.Phosphorylates PML at &apos;Ser-565&apos; and primes it for ubiquitin-mediated degradation. Plays an important role in the circadianclock function by phosphorylating ARNTL/BMAL1 at &apos;Ser-90&apos; which ispivotal for its interaction with CLOCK and which controls CLOCKnuclear entry (PubMed:11239457, PubMed:11704824, PubMed:16193064,PubMed:19188443, PubMed:20625391, PubMed:22406621). PhosphorylatesCCAR2 at &apos;Thr-454&apos; in gastric carcinoma tissue (PubMed:24962073).{ECO:0000269|PubMed:11239457, ECO:0000269|PubMed:11704824,ECO:0000269|PubMed:16193064, ECO:0000269|PubMed:19188443,ECO:0000269|PubMed:20625391, ECO:0000269|PubMed:22406621,ECO:0000269|PubMed:24962073}.CATALYTIC ACTIVITY:Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999,ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216;EC=2.7.11.1; Evidence={ECO:0000269|PubMed:20625391};CATALYTIC ACTIVITY:Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;EC=2.7.11.1; Evidence={ECO:0000269|PubMed:20625391};ACTIVITY REGULATION: Constitutively active protein kinase whoseactivity is not directly affected by phosphorylation. Seems to beregulated by level of expression and localization.SUBUNIT: Heterotetramer composed of two catalytic subunits (alphachain and/or alpha&apos; chain) and two regulatory subunits (betachains). The tetramer can exist as a combination of 2 alpha/2beta, 2 alpha&apos;/2 beta or 1 alpha/1 alpha&apos;/2 beta subunits. Alsopart of a CK2-SPT16-SSRP1 complex composed of SSRP1, SUPT16H,CSNK2A1, CSNK2A2 and CSNK2B, which forms following UV irradiation.Interacts with RNPS1. Interacts with SNAI1. Interacts with PML(isoform PML-12). Interacts with CCAR2.{ECO:0000269|PubMed:11092945, ECO:0000269|PubMed:11239457,ECO:0000269|PubMed:11574463, ECO:0000269|PubMed:12393879,ECO:0000269|PubMed:15684395, ECO:0000269|PubMed:19923321,ECO:0000269|PubMed:20625391, ECO:0000269|PubMed:22406621,ECO:0000269|PubMed:24962073}.SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24962073}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P68400-1; Sequence=Displayed;Name=2;IsoId=P68400-2; Sequence=VSP_041925;TISSUE SPECIFICITY: Expressed in gastric carcinoma tissue and theexpression gradually increases with the progression of thecarcinoma (at protein level). {ECO:0000269|PubMed:24962073}.PTM: Phosphorylated at Thr-344, Thr-360, Ser-362 and Ser-370 byCDK1 in prophase and metaphase and dephosphorylated duringanaphase. Phosphorylation does not directly affect casein kinase 2activity, but may contribute to its regulation by forming bindingsites for interacting proteins and/or targeting it to differentcompartments. {ECO:0000269|PubMed:7592773}.DISEASE: Okur-Chung neurodevelopmental syndrome (OCNDS)[MIM:617062]: An autosomal dominant neurodevelopmental disordercharacterized by developmental delay, intellectual disability,behavioral problems, hypotonia, speech problems, microcephaly,pachygyria and variable dysmorphic features.{ECO:0000269|PubMed:27048600}. Note=The disease is caused bymutations affecting the gene represented in this entry.MISCELLANEOUS: Can use both ATP and GTP as phosphoryl donors.Phosphorylation by casein kinase 2 has been estimated to representup to one quarter of the eukaryotic phosphoproteome. Casein kinase2 has been found to be increased at protein level and up-regulatedat the level of enzyme activity in the majority of cancers.However, elevated levels of casein kinase 2 are present in certainnormal organs such as brain and testes.SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thrprotein kinase family. CK2 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License.</bp:comment>
</bp:ProteinReference>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f0a611be32b23ae3d4dd9c6af8b98ce6">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/26692334" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f0a611be32b23ae3d4dd9c6af8b98ce6</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_ba603f9b6a726471ae00d97c6b116e2f">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">smMLCK</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">smMLCK (rabbit)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_ba603f9b6a726471ae00d97c6b116e2f</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_9e8c0dcd30294671702f0bd1e9cc44a5">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/27184836" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_9e8c0dcd30294671702f0bd1e9cc44a5</bp:comment>
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_d8219bc2-34a9-4683-ac58-61551ab304afhttp___www_phosphosite_org_phosphosite_owl_recid_3359218">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_d8219bc2-34a9-4683-ac58-61551ab304afhttp___www_phosphosite_org_phosphosite_owl_recid_3359218</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4063; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, lung/untreated; &lt;b&gt;Disease:&lt;/b&gt; non-small cell lung cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359218</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16943195">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2006</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16943195</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholemman phosphorylation alters its fluorescence resonance energy transfer with the Na/K-ATPase pump.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9011</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/22424773">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2012</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">22424773</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proteomic Investigations Reveal a Role for RNA Processing Factor THRAP3 in the DNA Damage Response.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=25227613</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/17924679">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">17924679</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=1676706</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_943e7eb1-da6d-4436-b484-a5271468b485http___www_phosphosite_org_phosphosite_owl_recid_3359210">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_943e7eb1-da6d-4436-b484-a5271468b485http___www_phosphosite_org_phosphosite_owl_recid_3359210</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4062; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, lung/untreated; &lt;b&gt;Disease:&lt;/b&gt; non-small cell lung cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359210</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_afb96caa0c496efae8ce4175ed60f927">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GJA1</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">GJA1 (rat)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_afb96caa0c496efae8ce4175ed60f927</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_bc925e06a06ccad92bea220d16569b9f">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_e90dcfc7-3472-48d7-a397-e7e3739b5e79http___www_phosphosite_org_phosphosite_owl_recid_3358644" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_bc925e06a06ccad92bea220d16569b9f</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_f3c418ddcf2a8a07c60891aca3529587">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DYRK1A</bp:displayName>
 <bp:entityReference rdf:resource="http://pathwaycommons.org/pc12/ProteinReference_b956204933388ca20b98452a46372612" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DYRK1A (mouse)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_f3c418ddcf2a8a07c60891aca3529587</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_9cf75c6c5ed05c760a33bc9612a2a8ac">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17562708" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_9cf75c6c5ed05c760a33bc9612a2a8ac</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:ProteinReference rdf:about="http://identifiers.org/uniprot/P06493">
 <bp:standardName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cyclin-dependent kinase 1</bp:standardName>
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P06493" />
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_CDK1_identity" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK1_HUMAN</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cell division control protein 2 homolog</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P34CDC2</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2.7.11.22</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p34 protein kinase</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC28A</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cell division protein kinase 1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDKN1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2.7.11.23</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDC2</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK1_HUMAN Reviewed; 297 AA.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FUNCTION: Plays a key role in the control of the eukaryotic cellcycle by modulating the centrosome cycle as well as mitotic onset;promotes G2-M transition, and regulates G1 progress and G1-Stransition via association with multiple interphase cyclins.Required in higher cells for entry into S-phase and mitosis.Phosphorylates PARVA/actopaxin, APC, AMPH, APC, BARD1, Bcl-xL/BCL2L1, BRCA2, CALD1, CASP8, CDC7, CDC20, CDC25A, CDC25C,CC2D1A, CENPA, CSNK2 proteins/CKII, FZR1/CDH1, CDK7, CEBPB,CHAMP1, DMD/dystrophin, EEF1 proteins/EF-1, EZH2, KIF11/EG5, EGFR,FANCG, FOS, GFAP, GOLGA2/GM130, GRASP1, UBE2A/hHR6A, HIST1H1proteins/histone H1, HMGA1, HIVEP3/KRC, LMNA, LMNB, LMNC, LBR,LATS1, MAP1B, MAP4, MARCKS, MCM2, MCM4, MKLP1, MYB, NEFH, NFIC,NPC/nuclear pore complex, PITPNM1/NIR2, NPM1, NCL, NUCKS1,NPM1/numatrin, ORC1, PRKAR2A, EEF1E1/p18, EIF3F/p47, p53/TP53,NONO/p54NRB, PAPOLA, PLEC/plectin, RB1, UL40/R2, RAB4A, RAP1GAP,RCC1, RPS6KB1/S6K1, KHDRBS1/SAM68, ESPL1, SKI, BIRC5/survivin,STIP1, TEX14, beta-tubulins, MAPT/TAU, NEDD1, VIM/vimentin, TK1,FOXO1, RUNX1/AML1, SAMHD1, SIRT2 and RUNX2. CDK1/CDC2-cyclin-Bcontrols pronuclear union in interphase fertilized eggs. Essentialfor early stages of embryonic development. During G2 and earlymitosis, CDC25A/B/C-mediated dephosphorylation activatesCDK1/cyclin complexes which phosphorylate several substrates thattrigger at least centrosome separation, Golgi dynamics, nuclearenvelope breakdown and chromosome condensation. Once chromosomesare condensed and aligned at the metaphase plate, CDK1 activity isswitched off by WEE1- and PKMYT1-mediated phosphorylation to allowsister chromatid separation, chromosome decondensation,reformation of the nuclear envelope and cytokinesis. Inactivatedby PKR/EIF2AK2- and WEE1-mediated phosphorylation upon DNA damageto stop cell cycle and genome replication at the G2 checkpointthus facilitating DNA repair. Reactivated after successful DNArepair through WIP1-dependent signaling leading to CDC25A/B/C-mediated dephosphorylation and restoring cell cycle progression.In proliferating cells, CDK1-mediated FOXO1 phosphorylation at theG2-M phase represses FOXO1 interaction with 14-3-3 proteins andthereby promotes FOXO1 nuclear accumulation and transcriptionfactor activity, leading to cell death of postmitotic neurons. Thephosphorylation of beta-tubulins regulates microtubule dynamicsduring mitosis. NEDD1 phosphorylation promotes PLK1-mediated NEDD1phosphorylation and subsequent targeting of the gamma-tubulin ringcomplex (gTuRC) to the centrosome, an important step for spindleformation. In addition, CC2D1A phosphorylation regulates CC2D1Aspindle pole localization and association with SCC1/RAD21 andcentriole cohesion during mitosis. The phosphorylation of Bcl-xL/BCL2L1 after prolongated G2 arrest upon DNA damage triggersapoptosis. In contrast, CASP8 phosphorylation during mitosisprevents its activation by proteolysis and subsequent apoptosis.This phosphorylation occurs in cancer cell lines, as well as inprimary breast tissues and lymphocytes. EZH2 phosphorylationpromotes H3K27me3 maintenance and epigenetic gene silencing. CALD1phosphorylation promotes Schwann cell migration during peripheralnerve regeneration. CDK1-cyclin-B complex phosphorylates NCKAP5Land mediates its dissociation from centrosomes during mitosis(PubMed:26549230). Regulates the amplitude of the cyclicexpression of the core clock gene ARNTL/BMAL1 by phosphorylatingits transcriptional repressor NR1D1, and this phosphorylation isnecessary for SCF(FBXW7)-mediated ubiquitination and proteasomaldegradation of NR1D1 (PubMed:27238018).{ECO:0000269|PubMed:16371510, ECO:0000269|PubMed:16407259,ECO:0000269|PubMed:16933150, ECO:0000269|PubMed:17459720,ECO:0000269|PubMed:18356527, ECO:0000269|PubMed:18480403,ECO:0000269|PubMed:19509060, ECO:0000269|PubMed:19917720,ECO:0000269|PubMed:20171170, ECO:0000269|PubMed:20360007,ECO:0000269|PubMed:20395957, ECO:0000269|PubMed:20935635,ECO:0000269|PubMed:20937773, ECO:0000269|PubMed:21063390,ECO:0000269|PubMed:23601106, ECO:0000269|PubMed:23602554,ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26549230,ECO:0000269|PubMed:27238018}.FUNCTION: (Microbial infection) Acts as a receptor for hepatitis Cvirus (HCV) in hepatocytes and facilitates its cell entry.{ECO:0000269|PubMed:21516087}.CATALYTIC ACTIVITY:Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999,ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216;EC=2.7.11.22;CATALYTIC ACTIVITY:Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;EC=2.7.11.22;CATALYTIC ACTIVITY:Reaction=[DNA-directed RNA polymerase] + ATP = ADP + H(+) +phospho-[DNA-directed RNA polymerase]; Xref=Rhea:RHEA:10216,Rhea:RHEA-COMP:11321, Rhea:RHEA-COMP:11322, ChEBI:CHEBI:15378,ChEBI:CHEBI:30616, ChEBI:CHEBI:43176, ChEBI:CHEBI:68546,ChEBI:CHEBI:456216; EC=2.7.11.23;ACTIVITY REGULATION: Phosphorylation at Thr-14 or Tyr-15inactivates the enzyme, while phosphorylation at Thr-161 activatesit. Activated through a multistep process; binding to cyclin-B isrequired for relocation of cyclin-kinase complexes to the nucleus,activated by CAK/CDK7-mediated phosphorylation on Thr-161, andCDC25-mediated dephosphorylation of inhibitory phosphorylation onThr-14 and Tyr-15. Inhibited by flavopiridol and derivatives,pyrimidine derivatives, pyridine derivatives, purine derivatives,staurosporine, paullones, oxoindoles, indazole analogs, indolin-2-ones, pyrazolo[3,4-b]pyridines, imidazo[1,2-a]pyridine (AZ703),thiazolinone analogs(RO-3306), thiazol urea, macrocyclicquinoxalin-2-one, pyrrolo[2,3-a]carbazole, pyrazolo[1,5-a]-1,3,5-triazine, pyrazolo[1,5-a]pyrimidine (Dinaciclib, SCH 727965), 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine(roscovitine), olomoucine, AG-024322, AT-7519, P276-00, R547/Ro-4584820 and SNS-032/BMS-387032. Repressed by the CDK inhibitorsCDKN1A/p21 and CDKN1B/p27 during the G1 phase and by CDKN1A/p21 atthe G1-S checkpoint upon DNA damage. Transient activation by rapidand transient dephosphorylation at Tyr-15 triggered by TGFB1.{ECO:0000269|PubMed:17459720, ECO:0000269|PubMed:9030781}.SUBUNIT: Forms a stable but non-covalent complex with a regulatorysubunit and with a cyclin. Interacts with cyclins-B (CCNB1, CCNB2and CCNB3) to form a serine/threonine kinase holoenzyme complexalso known as maturation promoting factor (MPF). The cyclinsubunit imparts substrate specificity to the complex. Can alsoform CDK1-cylin-D and CDK1-cyclin-E complexes that phosphorylateRB1 in vitro. Binds to RB1 and other transcription factors such asFOXO1 and RUNX2. Promotes G2-M transition when in complex with acyclin-B. Interacts with DLGAP5. Binds to the CDK inhibitorsCDKN1A/p21 and CDKN1B/p27. Isoform 2 is unable to complex withcyclin-B1 and also fails to bind to CDKN1A/p21. Interacts withcatalytically active CCNB1 and RALBP1 during mitosis to form anendocytotic complex during interphase. Associates with cyclins-Aand B1 during S-phase in regenerating hepatocytes. Interacts withFANCC. Interacts with CEP63; this interaction recruits CDK1 tocentrosomes. Interacts with CENPA (PubMed:25556658). Interactswith NR1D1 (PubMed:27238018). {ECO:0000269|PubMed:12775724,ECO:0000269|PubMed:15145941, ECO:0000269|PubMed:18356527,ECO:0000269|PubMed:20360007, ECO:0000269|PubMed:21406398,ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:27238018,ECO:0000269|PubMed:9242535}.SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Mitochondrion.Cytoplasm, cytoskeleton, microtubule organizing center, centrosome{ECO:0000269|PubMed:14654843}. Cytoplasm, cytoskeleton, spindle.Note=Cytoplasmic during the interphase. Colocalizes with SIRT2 oncentrosome during prophase and on splindle fibers during metaphaseof the mitotic cell cycle. Reversibly translocated from cytoplasmto nucleus when phosphorylated before G2-M transition whenassociated with cyclin-B1. Accumulates in mitochondria in G2-arrested cells upon DNA-damage.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1;IsoId=P06493-1; Sequence=Displayed;Name=2; Synonyms=CDC2deltaT;IsoId=P06493-2; Sequence=VSP_021375;TISSUE SPECIFICITY: Isoform 2 is found in breast cancer tissues.INDUCTION: Follows a cyclic expression; during interphase,accumulates gradually following G1, S to reach a criticalthreshold at the end of G2, which promotes self-activation andtriggers onset of mitosis. Induced transiently by TGFB1 at anearly phase of TGFB1-mediated apoptosis, but later repressed.Triggered by CKS1B during mitotic entry in breast cancer cells.Down-regulated under genotoxic stresses triggered by PKR/EIF2AK2-mediated phosphorylation. {ECO:0000269|PubMed:17459720,ECO:0000269|PubMed:18056467}.PTM: Phosphorylation at Thr-161 by CAK/CDK7 activates kinaseactivity. Phosphorylation at Thr-14 and Tyr-15 by PKMYT1 preventsnuclear translocation. Phosphorylation at Tyr-15 by WEE1 and WEE2inhibits the protein kinase activity and acts as a negativeregulator of entry into mitosis (G2 to M transition).Phosphorylation by PKMYT1 and WEE1 takes place during mitosis tokeep CDK1-cyclin-B complexes inactive until the end of G2. By theend of G2, PKMYT1 and WEE1 are inactivated, but CDC25A and CDC25Bare activated. Dephosphorylation by active CDC25A and CDC25B atThr-14 and Tyr-15, leads to CDK1 activation at the G2-Mtransition. Phosphorylation at Tyr-15 by WEE2 during oogenesis isrequired to maintain meiotic arrest in oocytes during the germinalvesicle (GV) stage, a long period of quiescence at dictyateprophase I, leading to prevent meiotic reentry. Phosphorylation byWEE2 is also required for metaphase II exit during egg activationto ensure exit from meiosis in oocytes and promote pronuclearformation. Phosphorylated at Tyr-4 by PKR/EIF2AK2 upon genotoxicstress. This phosphorylation triggers CDK1 polyubiquitination andsubsequent proteolysis, thus leading to G2 arrest. In response toUV irradiation, phosphorylation at Tyr-15 by PRKCD activates theG2/M DNA damage checkpoint. {ECO:0000269|PubMed:19917613,ECO:0000269|PubMed:20360007, ECO:0000269|PubMed:20395957,ECO:0000269|PubMed:3289755, ECO:0000269|PubMed:7569953}.PTM: Polyubiquitinated upon genotoxic stress.{ECO:0000269|PubMed:20395957}.MISCELLANEOUS: As a key regulator of the cell cycle, CDK1 is apotent therapeutic target for inhibitors in cancer treatment.{ECO:0000305|PubMed:21517772}.SIMILARITY: Belongs to the protein kinase superfamily. CMGCSer/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.SEQUENCE CAUTION:Sequence=EAW54204.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};WEB RESOURCE: Name=NIEHS-SNPs;URL=&quot;http://egp.gs.washington.edu/data/cdc2/&quot;; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://www.phosphosite.org/phosphosite.owl#po_582</bp:comment>
</bp:ProteinReference>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_fc38642033f30f951e6e7295bbc9f8ed">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16155364" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_fc38642033f30f951e6e7295bbc9f8ed</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_fa67ff56711e8a7971f0112e76afe538">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19276368" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_fa67ff56711e8a7971f0112e76afe538</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_dbe2f4d85d5d9e01fa2b3e2e13f28161">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18669648" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_dbe2f4d85d5d9e01fa2b3e2e13f28161</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_bfef3f78240662f3757ef5b2b0485a80">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20308788" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_bfef3f78240662f3757ef5b2b0485a80</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_1e06e06ea7b6fb1e98657aefd7928f74">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/25378699" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_1e06e06ea7b6fb1e98657aefd7928f74</bp:comment>
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/18315566">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">18315566</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2151811</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_7fefcf160c5da2b11fb0b5c27967d7f4">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/27641626" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_7fefcf160c5da2b11fb0b5c27967d7f4</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_7627a9518f8d3392d513fb52c6bda5ea">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18691976" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_7627a9518f8d3392d513fb52c6bda5ea</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_4cc68a91e72856ec1629241bccedc75a">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16943195" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_4cc68a91e72856ec1629241bccedc75a</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f0a8824f333259b3e02b82e90aa61082">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17270732" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f0a8824f333259b3e02b82e90aa61082</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_0da07e5a-0779-479b-92ca-e7a374f52c8dhttp___www_phosphosite_org_phosphosite_owl_recid_3360102">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_0da07e5a-0779-479b-92ca-e7a374f52c8dhttp___www_phosphosite_org_phosphosite_owl_recid_3360102</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4390; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, K562/untreated; &lt;b&gt;Disease:&lt;/b&gt; chronic myelogenous leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; p[STY])</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3360102</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_23743c592e97b3e0c0c3d523a9c27416">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20308788" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_23743c592e97b3e0c0c3d523a9c27416</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_8b10cb82ff11ca12afbc90ac476bd73b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/22424773" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_8b10cb82ff11ca12afbc90ac476bd73b</bp:comment>
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_17f1b179-8191-4544-b71a-3ce3cceef00fhttp___www_phosphosite_org_phosphosite_owl_recid_4918534">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_17f1b179-8191-4544-b71a-3ce3cceef00fhttp___www_phosphosite_org_phosphosite_owl_recid_4918534</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 5469; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, Jurkat/untreated; &lt;b&gt;Disease:&lt;/b&gt; T cell leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; (K/R)XpSX(K/R)&lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-(Ser) PKC Substrate Antibody Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=2261&gt;2261&lt;/a&gt;, PTMScan(R) Phospho-PKC Substrate Motif (K/RXpSXK/R) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1985&gt;1985&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4918534</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20068231">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20068231</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=12558710</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_d4000598c5e94d93dd6dfddb4f655c6b">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_6000f091-4d80-42a9-85a4-ad5e95fdfdbbhttp___www_phosphosite_org_phosphosite_owl_recid_3359092" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_d4000598c5e94d93dd6dfddb4f655c6b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/12484777">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2002</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">12484777</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The environmental toxin arsenite induces tau hyperphosphorylation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2112</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_0afffb3e78f9d5a551adaaa817316fdd">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17008320" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_0afffb3e78f9d5a551adaaa817316fdd</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_c33fd2605eaba48f349e90ccd7b7fdf8">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGA2</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGA2 (mouse)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_c33fd2605eaba48f349e90ccd7b7fdf8</bp:comment>
</bp:Protein>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/22479341">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2012</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">22479341</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Protein phosphatase 1 dephosphorylates profilin-1 at ser-137.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=25083306</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_c619aba2a816969c96d62497b488692d">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_f7e42f9c-96bd-469d-9774-f43b12048f87http___www_phosphosite_org_phosphosite_owl_recid_3358926" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_c619aba2a816969c96d62497b488692d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_e90dcfc7-3472-48d7-a397-e7e3739b5e79http___www_phosphosite_org_phosphosite_owl_recid_3358644">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_e90dcfc7-3472-48d7-a397-e7e3739b5e79http___www_phosphosite_org_phosphosite_owl_recid_3358644</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3883; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, Jurkat/pervanadate; &lt;b&gt;Disease:&lt;/b&gt; T cell leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; p[STY])</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3358644</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/25159151">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2014</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">25159151</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=35508600</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a936b097697035b5053d4dc4f60d3f07">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/23312004" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a936b097697035b5053d4dc4f60d3f07</bp:comment>
</bp:Evidence>

<bp:RelationshipXref rdf:about="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_LYN_identity">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hgnc symbol</bp:db>
</bp:RelationshipXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_916b4ee63ca3b47861ef4f1a02b179bd">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tau iso8</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tau iso8 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_916b4ee63ca3b47861ef4f1a02b179bd</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_813069d7087b21b319714e2c925b3ae2">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16645045" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_813069d7087b21b319714e2c925b3ae2</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_426ebe9378029adcef5619459aba848c">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_139e21ef-2b4d-4de6-b7d5-6332467bc529http___www_phosphosite_org_phosphosite_owl_recid_3358536" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_426ebe9378029adcef5619459aba848c</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_1d4d6ee9d368c8a6e2cac0659165b572">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/22479341" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_1d4d6ee9d368c8a6e2cac0659165b572</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_d08380b23b817ccdb9eece8d16b81ea8">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_96435395-b708-4d1b-9799-7a096f427fc3http___www_phosphosite_org_phosphosite_owl_recid_3359334" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_d08380b23b817ccdb9eece8d16b81ea8</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_3e09600ac36144e9af27966ea971df25">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18234856" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_3e09600ac36144e9af27966ea971df25</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_2baf8bdafb3124a60f00a31d56a8e12b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15249677" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_2baf8bdafb3124a60f00a31d56a8e12b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f7d26507c7a88d28213ddf602d0f4ee3">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16877359" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f7d26507c7a88d28213ddf602d0f4ee3</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_ef8361a83e8b2c8132a30d73fc56d7ab">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_17f1b179-8191-4544-b71a-3ce3cceef00fhttp___www_phosphosite_org_phosphosite_owl_recid_4918534" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_ef8361a83e8b2c8132a30d73fc56d7ab</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a45e62c2c235f8dd63f7adaabce4cf52">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_77e6769e-954a-4094-9d84-99ce0902ec0ahttp___www_phosphosite_org_phosphosite_owl_recid_3360286" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a45e62c2c235f8dd63f7adaabce4cf52</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_ce629583e9f964f905b7439da1d60a1d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/11104762" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_ce629583e9f964f905b7439da1d60a1d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_ec9ff5fe26234a9cccb8086c7f94d2d1">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_698fd962-0249-4a04-96eb-921232f21cb2http___www_phosphosite_org_phosphosite_owl_recid_4147630" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_ec9ff5fe26234a9cccb8086c7f94d2d1</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_2c4c367ae86e6f3a073820fb6c00f421">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24757378" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_2c4c367ae86e6f3a073820fb6c00f421</bp:comment>
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/15364924">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2004</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">15364924</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=5955610</bp:url>
</bp:PublicationXref>

<bp:EvidenceCodeVocabulary rdf:about="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_molecular_interactions_ontology_MI_0074" />
 <bp:term rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">mutation analysis</bp:term>
</bp:EvidenceCodeVocabulary>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_807e70318d4f2ea94e51536dd09b0506">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17287340" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_807e70318d4f2ea94e51536dd09b0506</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_b065abf4cbd17def08d6f2135824f85e">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_fe87e3a9-a0b6-4f0a-9dc9-871385ebfedehttp___www_phosphosite_org_phosphosite_owl_recid_3360256" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_b065abf4cbd17def08d6f2135824f85e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/12176732">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2002</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">12176732</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Translocation of telokin by cGMP signaling in smooth muscle cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=8842</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/12226093">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2002</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">12226093</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=5955606</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20097925">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20097925</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=12558708</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/22115753">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2012</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">22115753</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=23938051</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f461e2c36c1f155b390ae76a94f68852">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/10636877" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f461e2c36c1f155b390ae76a94f68852</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_6a168c4c29a3eb9f12a41778c8ecf44d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24117733" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_6a168c4c29a3eb9f12a41778c8ecf44d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_a2712524-cd1b-40c7-96d0-220e66cd332ehttp___www_phosphosite_org_phosphosite_owl_recid_4918532">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_a2712524-cd1b-40c7-96d0-220e66cd332ehttp___www_phosphosite_org_phosphosite_owl_recid_4918532</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 5468; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, Jurkat/untreated; &lt;b&gt;Disease:&lt;/b&gt; T cell leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; (K/R)XpSX(K/R)&lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-(Ser) PKC Substrate Antibody Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=2261&gt;2261&lt;/a&gt;, PTMScan(R) Phospho-PKC Substrate Motif (K/RXpSXK/R) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1985&gt;1985&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4918532</bp:url>
</bp:PublicationXref>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P29597">
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRIMARY</bp:comment>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P29597</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">uniprot knowledgebase</bp:db>
</bp:UnificationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_212abeea6ef6bf72d0d5f18f95381e20">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20164059" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_212abeea6ef6bf72d0d5f18f95381e20</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:BiochemicalReaction rdf:about="http://pathwaycommons.org/pc12/BiochemicalReaction_a8bd9ac135676a62b0f0fb840c36ecd9">
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_fc38642033f30f951e6e7295bbc9f8ed" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_af15d6cb9eb4674127d4dbcd57a2291f" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a5d456dba60b50168f2cb429c9fac047" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_47c6ce94fa7cb780bb21fff1400fbffe" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f3b59a19bcd074c4cd71d7a62c04e40c" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a45e62c2c235f8dd63f7adaabce4cf52" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_73f528155d669989e67f2dcadb5d1017" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_9f02d61aa39e1c57a2407d662de5d01a" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_ec9ff5fe26234a9cccb8086c7f94d2d1" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a3122615ffa6ce441570856de4a7d87f" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_c2d71a067a0c4cee1fd91e4a080d4899" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_b065abf4cbd17def08d6f2135824f85e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_4cc68a91e72856ec1629241bccedc75a" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_58492f0f856b848096a5f25fb52bbc37" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_b30636df5cc3057220737d5cd4252ca2" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_44aa6afedcb89ee63968465c4eaa6b1b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_90abf6c06949a765683cc6494d6597a1" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_d4000598c5e94d93dd6dfddb4f655c6b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_b945e4ba7502166c4bc6fadf9737215e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a1544d8dda29f8484501418777147bea" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a8eb1a3501bb1995b0befb1582633290" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_556f824a2412518de96baff1e54cf925" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_5c5d45675f68be0fc3f02eaca6532f3c" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_67c3472a70cd2a3db45c0545794c5fe2" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_5737f6085ce5545e4db55a96a7d9c598" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_1b0839a064b1b56d7223f1eca041190e" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_df29491dfd113a860fef5b383ed96af5" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_3375e4d822db3246a0a5565981d89f3f" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_5670ec4206efeef20253e7c5a77e0de9" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_7e029d08f164a1ee562ee2b294867ce8" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_c619aba2a816969c96d62497b488692d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_91a161fcb3c2923035f04624d7537aa7" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_66246f0b28a691f352bac54836e12339" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_3cb4f57af657a752f52ba401c7db69b3" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_852fd9862a2f30f4d914c87b270fe37f" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_426ebe9378029adcef5619459aba848c" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_58dcd99ef985a3117f2a4ad1cb0c2b28" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_d08380b23b817ccdb9eece8d16b81ea8" />
 <bp:right rdf:resource="http://pathwaycommons.org/pc12/Protein_703cd2a28612abcf069a58a8693f3d24" />
 <bp:left rdf:resource="http://pathwaycommons.org/pc12/Protein_28b207cfbccb2f4231c4d82dd1f944a2" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/BiochemicalReaction_a8bd9ac135676a62b0f0fb840c36ecd9</bp:comment>
 <bp:conversionDirection rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEFT_TO_RIGHT</bp:conversionDirection>
</bp:BiochemicalReaction>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_67c3472a70cd2a3db45c0545794c5fe2">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_3a420741-3aab-499f-821f-f8656ffb62fchttp___www_phosphosite_org_phosphosite_owl_recid_3359322" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_67c3472a70cd2a3db45c0545794c5fe2</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:RelationshipXref rdf:about="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_TYK2_identity">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TYK2</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hgnc symbol</bp:db>
</bp:RelationshipXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_5737f6085ce5545e4db55a96a7d9c598">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_b570d62f-eb36-4588-8d4b-ac4127f8982dhttp___www_phosphosite_org_phosphosite_owl_recid_3359308" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_5737f6085ce5545e4db55a96a7d9c598</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16923168">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2006</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16923168</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9223</bp:url>
</bp:PublicationXref>

<bp:BiochemicalReaction rdf:about="http://pathwaycommons.org/pc12/BiochemicalReaction_a35d892c9b16f11053b958a2cf7e899c">
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_3f828b989a839ca7899ee96bd1fb0b32" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_70407c3525d62d93b8bb0a1f1e0e67d5" />
 <bp:right rdf:resource="http://pathwaycommons.org/pc12/Protein_20772cf47d93731fcb6b2123e6f19c52" />
 <bp:left rdf:resource="http://pathwaycommons.org/pc12/Protein_ea1b457320fff6f706710b5652d8cb58" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/BiochemicalReaction_a35d892c9b16f11053b958a2cf7e899c</bp:comment>
 <bp:conversionDirection rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEFT_TO_RIGHT</bp:conversionDirection>
</bp:BiochemicalReaction>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/17287340">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">17287340</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9358</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_35647107cc9901f67ca6990dfc8f9771">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17971449" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_35647107cc9901f67ca6990dfc8f9771</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20886841">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20886841</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphoproteomic Analysis Reveals Site-Specific Changes in GFAP and NDRG2 Phosphorylation in Frontotemporal Lobar Degeneration.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=17335001</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_0f59d126fefce868fc8d21072b3c4211">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/12484777" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_0f59d126fefce868fc8d21072b3c4211</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_1d0ca4583588a30b832d428c04d5da43">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/29760653" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_1d0ca4583588a30b832d428c04d5da43</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_7cb05f1aecb30419dec9bb4ee6d43509">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24075978" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_7cb05f1aecb30419dec9bb4ee6d43509</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_49bd4922de2801f9ef5fe266097334e3">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/27281782" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_49bd4922de2801f9ef5fe266097334e3</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/12414518">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2002</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">12414518</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=5955607</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_3913e3693485176d59cfcd643450998d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/14761950" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_3913e3693485176d59cfcd643450998d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_71da71856973cede6166d949dba02707">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21659604" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_71da71856973cede6166d949dba02707</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_926fad8c1e8743a5cc93556818caef16">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">H1E</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">H1E (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_926fad8c1e8743a5cc93556818caef16</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_af15d6cb9eb4674127d4dbcd57a2291f">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_2ca8d6eb-d5dc-420c-9133-4d150673f602http___www_phosphosite_org_phosphosite_owl_recid_3358922" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_af15d6cb9eb4674127d4dbcd57a2291f</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_molecular_interactions_ontology_MI_0074">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MI:0074</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">molecular interactions ontology</bp:db>
</bp:UnificationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/15621037">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2005</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">15621037</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Serine 68 phosphorylation of phospholemman: acute isoform-specific activation of cardiac Na/K ATPase.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4428</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_da33f782974b8542632cfac0bfdf8bf9">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21731772" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_da33f782974b8542632cfac0bfdf8bf9</bp:comment>
</bp:Evidence>

<bp:ProteinReference rdf:about="http://identifiers.org/uniprot/P06213">
 <bp:standardName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Insulin receptor</bp:standardName>
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P06213" />
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_INSR_identity" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INSR_HUMAN</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CD220</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2.7.10.1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INSR</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Insulin receptor subunit alpha</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">IR</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Insulin receptor subunit beta</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://www.phosphosite.org/phosphosite.owl#po_4022</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FUNCTION: Receptor tyrosine kinase which mediates the pleiotropicactions of insulin. Binding of insulin leads to phosphorylation ofseveral intracellular substrates, including, insulin receptorsubstrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signalingintermediates. Each of these phosphorylated proteins serve asdocking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognizedifferent phosphotyrosine residues, including the p85 regulatorysubunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead tothe activation of two main signaling pathways: the PI3K-AKT/PKBpathway, which is responsible for most of the metabolic actions ofinsulin, and the Ras-MAPK pathway, which regulates expression ofsome genes and cooperates with the PI3K pathway to control cellgrowth and differentiation. Binding of the SH2 domains of PI3K tophosphotyrosines on IRS1 leads to the activation of PI3K and thegeneration of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3),a lipid second messenger, which activates several PIP3-dependentserine/threonine kinases, such as PDPK1 and subsequently AKT/PKB.The net effect of this pathway is to produce a translocation ofthe glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles tothe cell membrane to facilitate glucose transport. Moreover, uponinsulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD;regulates the expression of gluconeogenic and lipogenic enzymes bycontrolling the activity of the winged helix or forkhead (FOX)class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulatescell growth and metabolism and integrates signals from insulin.AKT mediates insulin-stimulated protein synthesis byphosphorylating TSC2 thereby activating mTORC1 pathway. TheRas/RAF/MAP2K/MAPK pathway is mainly involved in mediating cellgrowth, survival and cellular differentiation of insulin.Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers theactivation of the Ras/RAF/MAP2K/MAPK pathway. In addition tobinding insulin, the insulin receptor can bind insulin-like growthfactors (IGFI and IGFII). Isoform Short has a higher affinity forIGFII binding. When present in a hybrid receptor with IGF1R, bindsIGF1. PubMed:12138094 shows that hybrid receptors composed ofIGF1R and INSR isoform Long are activated with a high affinity byIGF1, with low affinity by IGF2 and not significantly activated byinsulin, and that hybrid receptors composed of IGF1R and INSRisoform Short are activated by IGF1, IGF2 and insulin. Incontrast, PubMed:16831875 shows that hybrid receptors composed ofIGF1R and INSR isoform Long and hybrid receptors composed of IGF1Rand INSR isoform Short have similar binding characteristics, bothbind IGF1 and have a low affinity for insulin. In adipocytes,inhibits lipolysis (By similarity). {ECO:0000250|UniProtKB:P15208,ECO:0000269|PubMed:12138094, ECO:0000269|PubMed:16314505,ECO:0000269|PubMed:16831875, ECO:0000269|PubMed:8257688,ECO:0000269|PubMed:8276809, ECO:0000269|PubMed:8452530,ECO:0000269|PubMed:9428692}.CATALYTIC ACTIVITY:Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-[protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136,Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216;EC=2.7.10.1; Evidence={ECO:0000255|PROSITE-ProRule:PRU10028,ECO:0000269|PubMed:11124964, ECO:0000269|PubMed:11598120,ECO:0000269|PubMed:12707268, ECO:0000269|PubMed:18278056,ECO:0000269|PubMed:19056263, ECO:0000269|PubMed:19071018,ECO:0000269|PubMed:19394223, ECO:0000269|PubMed:9312016};ACTIVITY REGULATION: Activated in response to insulin.Autophosphorylation activates the kinase activity. PTPN1, PTPREand PTPRF dephosphorylate important tyrosine residues, therebyreducing INSR activity. Inhibited by ENPP1. GRB10 and GRB14inhibit the catalytic activity of the INSR, they block access ofsubstrates to the activated receptor. SOCS1 and SOCS3 act asnegative regulators of INSR activity, they bind to the activatedINRS and interfere with the phosphorylation of INSR substrates.{ECO:0000269|PubMed:10615944, ECO:0000269|PubMed:11598120,ECO:0000269|PubMed:11726652, ECO:0000269|PubMed:12493740,ECO:0000269|PubMed:2211730}.SUBUNIT: Tetramer of 2 alpha and 2 beta chains linked by disulfidebonds. The alpha chains carry the insulin-binding regions, whilethe beta chains carry the kinase domain. Forms a hybrid receptorwith IGF1R, the hybrid is a tetramer consisting of 1 alpha chainand 1 beta chain of INSR and 1 alpha chain and 1 beta chain ofIGF1R. Interacts with SORBS1 but dissociates from it followinginsulin stimulation. Binds SH2B2. Activated form of INSR interacts(via Tyr-999) with the PTB/PID domains of IRS1 and SHC1. Thesequences surrounding the phosphorylated NPXY motif contributedifferentially to either IRS1 or SHC1 recognition. Interacts (viatyrosines in the C-terminus) with IRS2 (via PTB domain and 591-786AA); the 591-786 would be the primary anchor of IRS2 to INSR whilethe PTB domain would have a stabilizing action on the interactionwith INSR. Interacts with the SH2 domains of the 85 kDa regulatorysubunit of PI3K (PIK3R1) in vitro, when autophosphorylated ontyrosine residues. Interacts with SOCS7. Interacts (via thephosphorylated Tyr-999), with SOCS3. Interacts (via thephosphorylated Tyr-1185, Tyr-1189, Tyr-1190) with SOCS1. Interactswith CAV2 (tyrosine-phosphorylated form); the interaction isincreased with &apos;Tyr-27&apos;phosphorylation of CAV2 (By similarity).Interacts with ARRB2 (By similarity). Interacts with GRB10; thisinteraction blocks the association between IRS1/IRS2 and INSR,significantly reduces insulin-stimulated tyrosine phosphorylationof IRS1 and IRS2 and thus decreases insulin signaling. Interactswith GRB7. Interacts with PDPK1. Interacts (via Tyr-1190) withGRB14 (via BPS domain); this interaction protects the tyrosines inthe activation loop from dephosphorylation, but promotesdephosphorylation of Tyr-999, this results in decreasedinteraction with, and phosphorylation of, IRS1. Interacts (viasubunit alpha) with ENPP1 (via 485-599 AA); this interactionblocks autophosphorylation. Interacts with PTPRE; this interactionis dependent of Tyr-1185, Tyr-1189 and Tyr-1190 of the INSR.Interacts with STAT5B (via SH2 domain). Interacts with PTPRF.Interacts with ATIC; ATIC together with PRKAA2/AMPK2 andHACD3/PTPLAD1 is proposed to be part of a signaling netwokregulating INSR autophosphorylation and endocytosis (Bysimilarity). Interacts with the cone snail venom insulin Con-InsG1 (PubMed:27617429). Interacts with the insulin receptor SORL1;this interaction strongly increases its surface exposure, hencestrengthens insulin signal reception (PubMed:27322061).{ECO:0000250, ECO:0000250|UniProtKB:P15127,ECO:0000269|PubMed:10615944, ECO:0000269|PubMed:10803466,ECO:0000269|PubMed:11124964, ECO:0000269|PubMed:11374898,ECO:0000269|PubMed:11726652, ECO:0000269|PubMed:12493740,ECO:0000269|PubMed:14690593, ECO:0000269|PubMed:16127460,ECO:0000269|PubMed:16246733, ECO:0000269|PubMed:16271887,ECO:0000269|PubMed:16314505, ECO:0000269|PubMed:16957736,ECO:0000269|PubMed:18278056, ECO:0000269|PubMed:18767165,ECO:0000269|PubMed:19056263, ECO:0000269|PubMed:19071018,ECO:0000269|PubMed:19394223, ECO:0000269|PubMed:2211730,ECO:0000269|PubMed:23302862, ECO:0000269|PubMed:27322061,ECO:0000269|PubMed:27617429, ECO:0000269|PubMed:7537849,ECO:0000269|PubMed:7559478, ECO:0000269|PubMed:8276809,ECO:0000269|PubMed:8995282, ECO:0000269|PubMed:8999839,ECO:0000269|PubMed:9312016, ECO:0000269|PubMed:9428692}.SUBCELLULAR LOCATION: Cell membrane{ECO:0000250|UniProtKB:P15208}; Single-pass type I membraneprotein {ECO:0000305}. Late endosome{ECO:0000250|UniProtKB:P15208}. Lysosome{ECO:0000250|UniProtKB:P15208}. Note=Binding of insulin to INSRinduces internalization and lysosomal degradation of the receptor,a means for downregulating this signaling pathway afterstimulation. In the presence of SORL1, internalized INSR moleculesare redirected back to the cell surface, thereby preventing theirlysosomal catabolism and strengthening insulin signal reception.{ECO:0000250|UniProtKB:P15208}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=Long; Synonyms=HIR-B;IsoId=P06213-1; Sequence=Displayed;Name=Short; Synonyms=HIR-A;IsoId=P06213-2; Sequence=VSP_002898;TISSUE SPECIFICITY: Isoform Long and isoform Short arepredominantly expressed in tissue targets of insulin metaboliceffects: liver, adipose tissue and skeletal muscle but are alsoexpressed in the peripheral nerve, kidney, pulmonary alveoli,pancreatic acini, placenta vascular endothelium, fibroblasts,monocytes, granulocytes, erythrocytes and skin. Isoform Short ispreferentially expressed in fetal cells such as fetal fibroblasts,muscle, liver and kidney. Found as a hybrid receptor with IGF1R inmuscle, heart, kidney, adipose tissue, skeletal muscle, hepatoma,fibroblasts, spleen and placenta (at protein level). Overexpressedin several tumors, including breast, colon, lung, ovary, andthyroid carcinomas. {ECO:0000269|PubMed:10207053,ECO:0000269|PubMed:2369896, ECO:0000269|PubMed:9202395,ECO:0000269|PubMed:9355755}.DOMAIN: The tetrameric insulin receptor binds insulin via non-identical regions from two alpha chains, primarily via the C-terminal region of the first INSR alpha chain. Residues from theleucine-rich N-terminus of the other INSR alpha chain alsocontribute to this insulin binding site. A secondary insulin-binding site is formed by residues at the junction of fibronectintype-III domain 1 and 2. {ECO:0000269|PubMed:16957736,ECO:0000269|PubMed:19459609, ECO:0000269|PubMed:23302862}.PTM: After being transported from the endoplasmic reticulum to theGolgi apparatus, the single glycosylated precursor is furtherglycosylated and then cleaved, followed by its transport to theplasma membrane. {ECO:0000269|PubMed:1472036,ECO:0000269|PubMed:16894147, ECO:0000269|PubMed:19159218,ECO:0000269|PubMed:19349973, ECO:0000269|PubMed:23302862,ECO:0000269|PubMed:2983222}.PTM: Autophosphorylated on tyrosine residues in response toinsulin. Phosphorylation of Tyr-999 is required for binding toIRS1, SHC1 and STAT5B. Dephosphorylated by PTPRE at Tyr-999, Tyr-1185, Tyr-1189 and Tyr-1190. Dephosphorylated by PTPRF and PTPN1.Dephosphorylated by PTPN2; down-regulates insulin-inducedsignaling. {ECO:0000269|PubMed:10734133,ECO:0000269|PubMed:12612081, ECO:0000269|PubMed:14690593,ECO:0000269|PubMed:16246733, ECO:0000269|PubMed:16271887,ECO:0000269|PubMed:18278056, ECO:0000269|PubMed:18767165,ECO:0000269|PubMed:3166375, ECO:0000269|PubMed:9312016}.DISEASE: Rabson-Mendenhall syndrome (RMS) [MIM:262190]: Severeinsulin resistance syndrome characterized by insulin-resistantdiabetes mellitus with pineal hyperplasia and somaticabnormalities. Typical features include coarse, senile-appearingfacies, dental and skin abnormalities, abdominal distension, andphallic enlargement. Inheritance is autosomal recessive.{ECO:0000269|PubMed:10443650, ECO:0000269|PubMed:12023989,ECO:0000269|PubMed:17201797, ECO:0000269|PubMed:2121734,ECO:0000269|PubMed:2365819, ECO:0000269|PubMed:28765322,ECO:0000269|PubMed:8314008}. Note=The disease is caused bymutations affecting the gene represented in this entry.DISEASE: Leprechaunism (LEPRCH) [MIM:246200]: Represents the mostsevere form of insulin resistance syndrome, characterized byintrauterine and postnatal growth retardation and death in earlyinfancy. Inheritance is autosomal recessive.{ECO:0000269|PubMed:12023989, ECO:0000269|PubMed:12538626,ECO:0000269|PubMed:12970295, ECO:0000269|PubMed:1607067,ECO:0000269|PubMed:1730625, ECO:0000269|PubMed:22768670,ECO:0000269|PubMed:2365819, ECO:0000269|PubMed:24498630,ECO:0000269|PubMed:2479553, ECO:0000269|PubMed:2834824,ECO:0000269|PubMed:28765322, ECO:0000269|PubMed:7538143,ECO:0000269|PubMed:7815442, ECO:0000269|PubMed:8188715,ECO:0000269|PubMed:8326490, ECO:0000269|PubMed:8419945,ECO:0000269|PubMed:8636294, ECO:0000269|PubMed:9249867,ECO:0000269|PubMed:9299395, ECO:0000269|PubMed:9703342}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM)[MIM:125853]: A multifactorial disorder of glucose homeostasiscaused by a lack of sensitivity to the body&apos;s own insulin.Affected individuals usually have an obese body habitus andmanifestations of a metabolic syndrome characterized by diabetes,insulin resistance, hypertension and hypertriglyceridemia. Thedisease results in long-term complications that affect the eyes,kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:1470163,ECO:0000269|PubMed:1607076, ECO:0000269|PubMed:7657032}. Note=Thegene represented in this entry may be involved in diseasepathogenesis.DISEASE: Familial hyperinsulinemic hypoglycemia 5 (HHF5)[MIM:609968]: Familial hyperinsulinemic hypoglycemia [MIM:256450],also referred to as congenital hyperinsulinism, nesidioblastosis,or persistent hyperinsulinemic hypoglycemia of infancy (PPHI), isthe most common cause of persistent hypoglycemia in infancy and isdue to defective negative feedback regulation of insulin secretionby low glucose levels. {ECO:0000269|PubMed:15161766}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Insulin-resistant diabetes mellitus with acanthosisnigricans type A (IRAN type A) [MIM:610549]: Characterized by theassociation of severe insulin resistance (manifested by markedhyperinsulinemia and a failure to respond to exogenous insulin)with the skin lesion acanthosis nigricans and ovarianhyperandrogenism in adolescent female subjects. Women frequentlypresent with hirsutism, acne, amenorrhea or oligomenorrhea, andvirilization. This syndrome is different from the type B that hasbeen demonstrated to be secondary to the presence of circulatingautoantibodies against the insulin receptor.{ECO:0000269|PubMed:10733238, ECO:0000269|PubMed:11260230,ECO:0000269|PubMed:12107746, ECO:0000269|PubMed:12970295,ECO:0000269|PubMed:1563582, ECO:0000269|PubMed:1963473,ECO:0000269|PubMed:2002058, ECO:0000269|PubMed:2168397,ECO:0000269|PubMed:2365819, ECO:0000269|PubMed:2544998,ECO:0000269|PubMed:28765322, ECO:0000269|PubMed:3283938,ECO:0000269|PubMed:8243830, ECO:0000269|PubMed:8288049,ECO:0000269|PubMed:8314008, ECO:0000269|PubMed:8388389,ECO:0000269|PubMed:9175790}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the protein kinase superfamily. Tyr proteinkinase family. Insulin receptor subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.WEB RESOURCE: Name=Wikipedia; Note=Insulin receptor entry;URL=&quot;https://en.wikipedia.org/wiki/Insulin_receptor&quot;; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INSR_HUMAN Reviewed; 1382 AA.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://www.phosphosite.org/phosphosite.owl#po_608</bp:comment>
</bp:ProteinReference>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_0d85a224f3f11fbcba03d2d1f7dc9e61">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/9614189" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_0d85a224f3f11fbcba03d2d1f7dc9e61</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_8468612c8396d9ca971656cad0ba33e6">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17008320" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_8468612c8396d9ca971656cad0ba33e6</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:EvidenceCodeVocabulary rdf:about="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_molecular_interactions_ontology_MI_0427" />
 <bp:term rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Identification by mass spectrometry</bp:term>
</bp:EvidenceCodeVocabulary>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_655b60773d189deacc144b82775c8096">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tau iso8</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tau iso8 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_655b60773d189deacc144b82775c8096</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_aa3ad25fe666a6f289a194c57039e1b6">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/12414518" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_aa3ad25fe666a6f289a194c57039e1b6</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_139e21ef-2b4d-4de6-b7d5-6332467bc529http___www_phosphosite_org_phosphosite_owl_recid_3358536">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_139e21ef-2b4d-4de6-b7d5-6332467bc529http___www_phosphosite_org_phosphosite_owl_recid_3358536</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3871; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, lung/untreated; &lt;b&gt;Disease:&lt;/b&gt; non-small cell lung cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3358536</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/27235399">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2016</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">27235399</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Regulation of Connexin43 Function and Expression by Tyrosine Kinase 2.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=55530865</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/22617229">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2012</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">22617229</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphosignature predicts dasatinib response in non-small cell lung cancer.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=28701807</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_78f83f3ac869808dce673b9edbc54aaa">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/23628362" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_78f83f3ac869808dce673b9edbc54aaa</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/27641626">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2016</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">27641626</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Quantitative and combinatory determination of in situ phosphorylation of tau and its FTDP-17 mutants.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=59219405</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16787414">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2006</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16787414</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2422211</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f0c4a68a47dc4fac3dcc4406a7230b46">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20068231" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f0c4a68a47dc4fac3dcc4406a7230b46</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_64e4b31343502cc12d963b5f872b6bee">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/10981712" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_64e4b31343502cc12d963b5f872b6bee</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_787567869d58ddcefd5217d144197777">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20394726" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_787567869d58ddcefd5217d144197777</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_b945e4ba7502166c4bc6fadf9737215e">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_51d1caee-9dac-4c62-92ce-bf769cfd7877http___www_phosphosite_org_phosphosite_owl_recid_3358772" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_b945e4ba7502166c4bc6fadf9737215e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_bf828332b2dbe1382949fe4abc4f6493">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21857030" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_bf828332b2dbe1382949fe4abc4f6493</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_89266e8cdebccd2627fef740047e6d46">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18779572" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_89266e8cdebccd2627fef740047e6d46</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_20bf9b7864c0e525c8763412f1fa2f9b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15664690" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_20bf9b7864c0e525c8763412f1fa2f9b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_cc0db9f8a4794d077843be44a0b4385c">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19659459" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_cc0db9f8a4794d077843be44a0b4385c</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24113872">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24113872</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LRRK2 phosphorylates novel tau epitopes and promotes tauopathy.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=29552520</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_83327167b849c1611499b0ab3565bd9d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20506302" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_83327167b849c1611499b0ab3565bd9d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_f811415c-b835-440f-a939-b3d7df86e18ahttp___www_phosphosite_org_phosphosite_owl_recid_3358468">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_f811415c-b835-440f-a939-b3d7df86e18ahttp___www_phosphosite_org_phosphosite_owl_recid_3358468</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3869; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, lung/untreated; &lt;b&gt;Disease:&lt;/b&gt; non-small cell lung cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3358468</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/17270732">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">17270732</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2698009</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_d66a4e773830af69551f0ee3824e9d24">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15994305" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_d66a4e773830af69551f0ee3824e9d24</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_3d924f709a19dcf671afb6a62ccdcb9b">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">profilin 1</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">profilin 1 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_3d924f709a19dcf671afb6a62ccdcb9b</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_cf8c7bb3a8c30f69232144dbc7cf0f2e">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20466736" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_cf8c7bb3a8c30f69232144dbc7cf0f2e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f69befe7a7c31b6cfd95b642c375c04d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16923168" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f69befe7a7c31b6cfd95b642c375c04d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_bbc2b506ec9c925b070c24fb57eda29d">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_9a37d2df-3978-4a66-8ef8-d8e4ae4e5999http___www_phosphosite_org_phosphosite_owl_recid_9391600" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_bbc2b506ec9c925b070c24fb57eda29d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/25850435">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2015</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">25850435</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=51373300</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20686112">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20686112</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR).</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=18376920</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f6a55c82bfcd9a4cba93dcf7d7b592ab">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/22115753" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f6a55c82bfcd9a4cba93dcf7d7b592ab</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f9dfab2b67a5704ae2424a689175a4c0">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15364924" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f9dfab2b67a5704ae2424a689175a4c0</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_c74a68196d56fbfbe6197213c6bec416">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21918188" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_c74a68196d56fbfbe6197213c6bec416</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_3ae959782555281dc9ce99b029b9a3f7">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15664690" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_3ae959782555281dc9ce99b029b9a3f7</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/22547687">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2012</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">22547687</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphoproteomic analysis of leukemia cells under basal and drug-treated conditions identifies markers of kinase pathway activation and mechanisms of resistance.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=28701803</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_4032b3c8-22be-4932-9abe-7b76e886ef76http___www_phosphosite_org_phosphosite_owl_recid_3359224">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_4032b3c8-22be-4932-9abe-7b76e886ef76http___www_phosphosite_org_phosphosite_owl_recid_3359224</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4137; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, lung/untreated; &lt;b&gt;Disease:&lt;/b&gt; non-small cell lung cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359224</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_7ef986d5fb34cf8e480d79451d4b1e3a">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20159774" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_7ef986d5fb34cf8e480d79451d4b1e3a</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21918188">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21918188</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Myeloid Differentiation Factor-2 Interacts with Lyn Kinase and Is Tyrosine Phosphorylated Following Lipopolysaccharide-Induced Activation of the TLR4 Signaling Pathway.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=21386600</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_8d94f11e0727e27b58beaeb6a8004855">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/26209608" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_8d94f11e0727e27b58beaeb6a8004855</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_15800912e47ca49c5b11f7e8b570340e">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19451179" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_15800912e47ca49c5b11f7e8b570340e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_799d80d6-4945-4a56-9854-b1a0d507aca7http___www_phosphosite_org_phosphosite_owl_recid_3360100">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_799d80d6-4945-4a56-9854-b1a0d507aca7http___www_phosphosite_org_phosphosite_owl_recid_3360100</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4609; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, K562/untreated; &lt;b&gt;Disease:&lt;/b&gt; chronic myelogenous leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; p[STY])</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3360100</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16155364">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2005</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16155364</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Serine 68 phospholemman phosphorylation during forskolin-induced swine carotid artery relaxation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=7300</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20550628">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20550628</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The formation of tau pathological phospho-epitopes in the axon is prevented by the dephosphorylation of selective sites in primary hippocampal neurons over-expressing human tau.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=17630402</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_078a9710606b83029ad8545edc745a83">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/23749302" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_078a9710606b83029ad8545edc745a83</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:ProteinReference rdf:about="http://identifiers.org/uniprot/P29597">
 <bp:standardName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Non-receptor tyrosine-protein kinase TYK2</bp:standardName>
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P29597" />
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_TYK2_identity" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TYK2_HUMAN</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2.7.10.2</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TYK2</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">TYK2_HUMAN Reviewed; 1187 AA.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://www.phosphosite.org/phosphosite.owl#po_568</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FUNCTION: Probably involved in intracellular signal transductionby being involved in the initiation of type I IFN signaling.Phosphorylates the interferon-alpha/beta receptor alpha chain.{ECO:0000269|PubMed:7526154}.CATALYTIC ACTIVITY:Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-[protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136,Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216;EC=2.7.10.2; Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};SUBUNIT: Interacts with JAKMIP1. {ECO:0000269|PubMed:15277531,ECO:0000269|PubMed:20478313}.TISSUE SPECIFICITY: Observed in all cell lines analyzed. Expressedin a variety of lymphoid and non-lymphoid cell lines.{ECO:0000269|PubMed:2156206}.DOMAIN: The FERM domain mediates interaction with JAKMIP1.DISEASE: Immunodeficiency 35 (IMD35) [MIM:611521]: A primaryimmunodeficiency characterized by recurrent skin abscesses,pneumonia, and highly elevated serum IgE.{ECO:0000269|PubMed:17088085}. Note=The disease is caused bymutations affecting the gene represented in this entry.SIMILARITY: Belongs to the protein kinase superfamily. Tyr proteinkinase family. JAK subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.WEB RESOURCE: Name=TYK2base; Note=TYK2 mutation db;URL=&quot;http://structure.bmc.lu.se/idbase/TYK2base/&quot;;WEB RESOURCE: Name=SeattleSNPs;URL=&quot;http://pga.gs.washington.edu/data/tyk2/&quot;; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License.</bp:comment>
</bp:ProteinReference>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16155008">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2005</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16155008</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A positive feedback loop between glycogen synthase kinase 3beta and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=6931</bp:url>
</bp:PublicationXref>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P06213">
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRIMARY</bp:comment>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P06213</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">uniprot knowledgebase</bp:db>
</bp:UnificationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_08757aca9fa2d47754d365d6d67427a1">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/9556631" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_08757aca9fa2d47754d365d6d67427a1</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16877359">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2006</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16877359</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Alzheimer&apos;s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2519603</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_52050da2c1534808e290c3969c99110b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/23836654" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_52050da2c1534808e290c3969c99110b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a8eb1a3501bb1995b0befb1582633290">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_c7a5e4aa-1351-4d4c-99a4-233c6d0b0aa6http___www_phosphosite_org_phosphosite_owl_recid_4148186" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a8eb1a3501bb1995b0befb1582633290</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_77e6769e-954a-4094-9d84-99ce0902ec0ahttp___www_phosphosite_org_phosphosite_owl_recid_3360286">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_77e6769e-954a-4094-9d84-99ce0902ec0ahttp___www_phosphosite_org_phosphosite_owl_recid_3360286</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3913; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, liver/untreated; &lt;b&gt;Disease:&lt;/b&gt; liver cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3360286</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_6102340760ef8d36849309f3538c2cf9">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17270732" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_6102340760ef8d36849309f3538c2cf9</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/19413330">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19413330</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=7609001</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/14761950">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2004</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">14761950</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3579</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_c671fa9076c353625f6bb68e1e0d4bf1">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16645045" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_c671fa9076c353625f6bb68e1e0d4bf1</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_ae783e7d16d683b30e88b2e577d28257">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16095576" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_ae783e7d16d683b30e88b2e577d28257</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/27251275">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2016</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">27251275</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Proteogenomics connects somatic mutations to signalling in breast cancer.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=56627900</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/19690332">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19690332</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9924203</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_315f05d1b51305f2898e790f57b035bd">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/12414518" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_315f05d1b51305f2898e790f57b035bd</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/19664995">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19664995</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation dynamics during early differentiation of human embryonic stem cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9647402</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_6eeb5d765148f96f6882b14f72ad575e">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20394726" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_6eeb5d765148f96f6882b14f72ad575e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_70407c3525d62d93b8bb0a1f1e0e67d5">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/11401470" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_70407c3525d62d93b8bb0a1f1e0e67d5</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/15822905">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2005</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">15822905</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphoproteomic analysis of synaptosomes from human cerebral cortex.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=6887</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_be2e199d-7473-4543-99c1-bbccccf7c5b4http___www_phosphosite_org_phosphosite_owl_recid_3360080">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_be2e199d-7473-4543-99c1-bbccccf7c5b4http___www_phosphosite_org_phosphosite_owl_recid_3360080</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4605; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, K562/untreated; &lt;b&gt;Disease:&lt;/b&gt; chronic myelogenous leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; p[STY])</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3360080</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_b2215a265991d55b70aa61160cba622d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16923168" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_b2215a265991d55b70aa61160cba622d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_115088b6bbb0d717231f7f79d0ac758b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19664995" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_115088b6bbb0d717231f7f79d0ac758b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:RelationshipXref rdf:about="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_CSNK2A1_identity">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CSNK2A1</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hgnc symbol</bp:db>
</bp:RelationshipXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/18847512">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">18847512</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Identification of CDK2 substrates in human cell lysates.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4321202</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_aa32768a7b69fc9daa6838035b82c069">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18573880" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_aa32768a7b69fc9daa6838035b82c069</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/19472218">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19472218</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phospholipid transfer protein reduces phosphorylation of tau in human neuronal cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=11999200</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_478a79c626618753ab82c775e4550701">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_0da07e5a-0779-479b-92ca-e7a374f52c8dhttp___www_phosphosite_org_phosphosite_owl_recid_3360102" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_478a79c626618753ab82c775e4550701</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_e88abcd22777005ddef6184a9a8d19de">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24003220" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_e88abcd22777005ddef6184a9a8d19de</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_8904c60a812f289f53e222da18171fe3">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16397900" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_8904c60a812f289f53e222da18171fe3</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/23684622">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">23684622</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=28118814</bp:url>
</bp:PublicationXref>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P17612">
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRIMARY</bp:comment>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P17612</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">uniprot knowledgebase</bp:db>
</bp:UnificationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21220422">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21220422</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=18021013</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16115884">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2005</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16115884</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Disease-related modifications in tau affect the interaction between Fyn and Tau.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=7021</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_d2427a13ffe430d2d2446081f4f8a106">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16155008" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_d2427a13ffe430d2d2446081f4f8a106</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:RelationshipXref rdf:about="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_PRKACA_identity">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRKACA</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hgnc symbol</bp:db>
</bp:RelationshipXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a98f99b052bbbd62c1dc4d07c0d96613">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20394726" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a98f99b052bbbd62c1dc4d07c0d96613</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_d67a4a9eba384fcd7d7a7b235f5f3886">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/26555036" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_d67a4a9eba384fcd7d7a7b235f5f3886</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24073234">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24073234</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer&apos;s diseases.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=29642421</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/28814543">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2017</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">28814543</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=460257529</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/17906291">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2007</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">17906291</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=762739</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_5c5d45675f68be0fc3f02eaca6532f3c">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21220422" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_5c5d45675f68be0fc3f02eaca6532f3c</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21731772">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21731772</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Molecular implication of PP2A and Pin1 in the Alzheimer&apos;s disease specific hyperphosphorylation of Tau.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=21690612</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20363803">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20363803</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=13323400</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_9bf3355ac093a31615016f22f62e3a20">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/22496350" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_9bf3355ac093a31615016f22f62e3a20</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_16c3d9c359cd73e925b1acc65545f17d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17906291" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_16c3d9c359cd73e925b1acc65545f17d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20159774">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20159774</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=14821625</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_cb02e73fd41a45de7730c43043dec9e7">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20686112" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_cb02e73fd41a45de7730c43043dec9e7</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:BiochemicalReaction rdf:about="http://pathwaycommons.org/pc12/BiochemicalReaction_2f9032a2a45978cc0f1e28630f2887cf">
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_08757aca9fa2d47754d365d6d67427a1" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f610e620150f52982e652ab3f8f44047" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_64e4b31343502cc12d963b5f872b6bee" />
 <bp:right rdf:resource="http://pathwaycommons.org/pc12/Protein_ba603f9b6a726471ae00d97c6b116e2f" />
 <bp:left rdf:resource="http://pathwaycommons.org/pc12/Protein_bc76ad2d2f4075922ff2cd3f9313e857" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/BiochemicalReaction_2f9032a2a45978cc0f1e28630f2887cf</bp:comment>
 <bp:conversionDirection rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEFT_TO_RIGHT</bp:conversionDirection>
</bp:BiochemicalReaction>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24670416">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2014</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24670416</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=33623300</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_5cadbb2950674bf9db44d7b03fa3cc31">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/25681442" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_5cadbb2950674bf9db44d7b03fa3cc31</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_O14757">
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRIMARY</bp:comment>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">O14757</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">uniprot knowledgebase</bp:db>
</bp:UnificationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_80d7af68be4af035afe706bbac60ea92">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_9fbe7f0c-6610-4bee-b3b9-a671312b1d24http___www_phosphosite_org_phosphosite_owl_recid_9390598" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_80d7af68be4af035afe706bbac60ea92</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_86cf506d82bf7c7681a9f5f758a537f7">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/24312574" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_86cf506d82bf7c7681a9f5f758a537f7</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/16645045">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2006</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">16645045</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=2362500</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/18234856">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">18234856</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=1723801</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_456ed1f37b73aae5e59c15e68b1cd3ab">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/22479341" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_456ed1f37b73aae5e59c15e68b1cd3ab</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/8506352">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">1993</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">8506352</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=1301</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_260a6c1b06235272aa204270f9f954f9">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/22479341" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_260a6c1b06235272aa204270f9f954f9</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a0404efafb09b417d17a702de2b16249">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18573880" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a0404efafb09b417d17a702de2b16249</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:ProteinReference rdf:about="http://identifiers.org/uniprot/O14757">
 <bp:standardName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Serine/threonine-protein kinase Chk1</bp:standardName>
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_CHEK1_identity" />
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_O14757" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHK1_HUMAN</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHK1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Checkpoint kinase-1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2.7.11.1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHEK1</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Cell cycle checkpoint kinase</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHK1 checkpoint homolog</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FUNCTION: Serine/threonine-protein kinase which is required forcheckpoint-mediated cell cycle arrest and activation of DNA repairin response to the presence of DNA damage or unreplicated DNA. Mayalso negatively regulate cell cycle progression during unperturbedcell cycles. This regulation is achieved by a number of mechanismsthat together help to preserve the integrity of the genome.Recognizes the substrate consensus sequence [R-X-X-S/T]. Binds toand phosphorylates CDC25A, CDC25B and CDC25C. Phosphorylation ofCDC25A at &apos;Ser-178&apos; and &apos;Thr-507&apos; and phosphorylation of CDC25C at&apos;Ser-216&apos; creates binding sites for 14-3-3 proteins which inhibitCDC25A and CDC25C. Phosphorylation of CDC25A at &apos;Ser-76&apos;, &apos;Ser-124&apos;, &apos;Ser-178&apos;, &apos;Ser-279&apos; and &apos;Ser-293&apos; promotes proteolysis ofCDC25A. Phosphorylation of CDC25A at &apos;Ser-76&apos; primes the proteinfor subsequent phosphorylation at &apos;Ser-79&apos;, &apos;Ser-82&apos; and &apos;Ser-88&apos;by NEK11, which is required for polyubiquitination and degradationof CDCD25A. Inhibition of CDC25 leads to increased inhibitorytyrosine phosphorylation of CDK-cyclin complexes and blocks cellcycle progression. Also phosphorylates NEK6. Binds to andphosphorylates RAD51 at &apos;Thr-309&apos;, which promotes the release ofRAD51 from BRCA2 and enhances the association of RAD51 withchromatin, thereby promoting DNA repair by homologousrecombination. Phosphorylates multiple sites within the C-terminusof TP53, which promotes activation of TP53 by acetylation andpromotes cell cycle arrest and suppression of cellularproliferation. Also promotes repair of DNA cross-links throughphosphorylation of FANCE. Binds to and phosphorylates TLK1 at&apos;Ser-743&apos;, which prevents the TLK1-dependent phosphorylation ofthe chromatin assembly factor ASF1A. This may enhance chromatinassembly both in the presence or absence of DNA damage. May alsoplay a role in replication fork maintenance through regulation ofPCNA. May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones.Phosphorylates histone H3.1 (to form H3T11ph), which leads toepigenetic inhibition of a subset of genes. May also phosphorylateRB1 to promote its interaction with the E2F family oftranscription factors and subsequent cell cycle arrest.FUNCTION: Isoform 2: Endogenous repressor of isoform 1, interactswith, and antagonizes CHK1 to promote the S to G2/M phasetransition.CATALYTIC ACTIVITY:Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999,ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216;EC=2.7.11.1;CATALYTIC ACTIVITY:Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;EC=2.7.11.1;ACTIVITY REGULATION: Activated through phosphorylationpredominantly by ATR but also by ATM in response to DNA damage orinhibition of DNA replication. Activation is modulated by severalmediators including CLSPN, BRCA1 and FEM1B.SUBUNIT: Interacts (phosphorylated by ATR) with RAD51. Interactswith and phosphorylates CLSPN, an adapter protein that regulatesthe ATR-dependent phosphorylation of CHEK1. Interacts with BRCA1.Interacts with and phosphorylates CDC25A, CDC25B and CDC25C.Interacts with FBXO6, which regulates CHEK1. Interacts with PPM1D,which regulates CHEK1 through dephosphorylation. Interacts withTIMELESS; DNA damage-dependent. Interacts with FEM1B; activatesCHEK1 in response to stress. Interacts with TLK1. Interacts withXPO1 and YWHAZ. Isoform 1 associates with isoform 2, theinteraction is disrupted upon phosphorylation by ATR. Interactswith CDK5RAP3; antagonizes CHEK1 (PubMed:19223857).{ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12676962,ECO:0000269|PubMed:12766152, ECO:0000269|PubMed:15665856,ECO:0000269|PubMed:15707391, ECO:0000269|PubMed:15798197,ECO:0000269|PubMed:15870257, ECO:0000269|PubMed:16963448,ECO:0000269|PubMed:19223857, ECO:0000269|PubMed:19330022,ECO:0000269|PubMed:19716789, ECO:0000269|PubMed:9278511}.SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Cytoplasm, cytoskeleton,microtubule organizing center, centrosome. Note=Nuclear export ismediated at least in part by XPO1/CRM1. Also localizes to thecentrosome specifically during interphase, where it may protectcentrosomal CDC2 kinase from inappropriate activation bycytoplasmic CDC25B.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=3;Name=1;IsoId=O14757-1; Sequence=Displayed;Name=2; Synonyms=Chk1-short, Chk1-S;IsoId=O14757-2; Sequence=VSP_044008, VSP_044009;Name=3;IsoId=O14757-3; Sequence=VSP_045075;Note=No experimental confirmation available.;TISSUE SPECIFICITY: Expressed ubiquitously with the most abundantexpression in thymus, testis, small intestine and colon.{ECO:0000269|PubMed:9278511, ECO:0000269|PubMed:9382850}.DOMAIN: The autoinhibitory region (AIR) inhibits the activity ofthe kinase domain. {ECO:0000269|PubMed:14681223}.PTM: Phosphorylated by ATR in a RAD17-dependent manner in responseto ultraviolet irradiation and inhibition of DNA replication.Phosphorylated by ATM in response to ionizing irradiation. ATM andATR can both phosphorylate Ser-317 and Ser-345 and this results inenhanced kinase activity. Phosphorylation at Ser-345 induces achange in the conformation of the protein, activates the kinaseactivity and is a prerequisite for interaction with FBXO6 andsubsequent ubiquitination at Lys-436. Phosphorylation at Ser-345also increases binding to 14-3-3 proteins and promotes nuclearretention. Conversely, dephosphorylation at Ser-345 by PPM1D maycontribute to exit from checkpoint mediated cell cycle arrest.Phosphorylation at Ser-280 by AKT1/PKB, may promote mono and/ordiubiquitination. Also phosphorylated at undefined residues duringmitotic arrest, resulting in decreased activity.{ECO:0000269|PubMed:10859164, ECO:0000269|PubMed:11390642,ECO:0000269|PubMed:12446774, ECO:0000269|PubMed:12588868,ECO:0000269|PubMed:12660173, ECO:0000269|PubMed:12676583,ECO:0000269|PubMed:12676925, ECO:0000269|PubMed:12676962,ECO:0000269|PubMed:14657349, ECO:0000269|PubMed:14681223,ECO:0000269|PubMed:14988723, ECO:0000269|PubMed:15650047,ECO:0000269|PubMed:15707391, ECO:0000269|PubMed:15870257,ECO:0000269|PubMed:19716789}.PTM: Ubiquitinated. Mono or diubiquitination promotes nuclearexclusion (By similarity). The activated form (phosphorylated onSer-345) is polyubiquitinated at Lys-436 by some SCF-type E3ubiquitin ligase complex containing FBXO6 promoting itsdegradation. Ubiquitination and degradation are required toterminate the checkpoint and ensure that activated CHEK1 does notaccumulate as cells progress through S phase, when replicationforks encounter transient impediments during normal DNAreplication. {ECO:0000250, ECO:0000269|PubMed:10859164,ECO:0000269|PubMed:11390642, ECO:0000269|PubMed:12446774,ECO:0000269|PubMed:12676583, ECO:0000269|PubMed:12676925,ECO:0000269|PubMed:12676962, ECO:0000269|PubMed:14681223,ECO:0000269|PubMed:14988723, ECO:0000269|PubMed:15650047,ECO:0000269|PubMed:15707391, ECO:0000269|PubMed:15870257,ECO:0000269|PubMed:19716789}.SIMILARITY: Belongs to the protein kinase superfamily. CAMKSer/Thr protein kinase family. NIM1 subfamily. {ECO:0000305}.WEB RESOURCE: Name=NIEHS-SNPs;URL=&quot;http://egp.gs.washington.edu/data/chek1/&quot;; COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHK1_HUMAN Reviewed; 476 AA.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://www.phosphosite.org/phosphosite.owl#po_586</bp:comment>
</bp:ProteinReference>

<bp:BiochemicalReaction rdf:about="http://pathwaycommons.org/pc12/BiochemicalReaction_9d1305df603e0573d0497b2c2e5c247f">
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_bec7c74b7a5fab8cf217525cea53450d" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_260a6c1b06235272aa204270f9f954f9" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_a0404efafb09b417d17a702de2b16249" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_5cadbb2950674bf9db44d7b03fa3cc31" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_456ed1f37b73aae5e59c15e68b1cd3ab" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_1d4d6ee9d368c8a6e2cac0659165b572" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_aa32768a7b69fc9daa6838035b82c069" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_c869605aaadee75290791c26d2cc9f24" />
 <bp:right rdf:resource="http://pathwaycommons.org/pc12/Protein_953b46c6ae2bcc66dc85cc131625c4fa" />
 <bp:left rdf:resource="http://pathwaycommons.org/pc12/Protein_3d924f709a19dcf671afb6a62ccdcb9b" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/BiochemicalReaction_9d1305df603e0573d0497b2c2e5c247f</bp:comment>
 <bp:conversionDirection rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEFT_TO_RIGHT</bp:conversionDirection>
</bp:BiochemicalReaction>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_bbec2a0704c5d1fcfc1f7e5446200b14">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21327254" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_bbec2a0704c5d1fcfc1f7e5446200b14</bp:comment>
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/23312004">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">23312004</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=27423500</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/27184836">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2016</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">27184836</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Multiomic Analysis of the UV-Induced DNA Damage Response.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=55530829</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_5670ec4206efeef20253e7c5a77e0de9">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21653224" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_5670ec4206efeef20253e7c5a77e0de9</bp:comment>
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_20772cf47d93731fcb6b2123e6f19c52">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INSR iso2</bp:displayName>
 <bp:entityReference rdf:resource="http://identifiers.org/uniprot/P06213" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INSR iso2 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_20772cf47d93731fcb6b2123e6f19c52</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_482f30f2e0cc9270d2a21e8b31eb470c">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/27235399" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_482f30f2e0cc9270d2a21e8b31eb470c</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20860994">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20860994</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The Plk1-dependent phosphoproteome of the early mitotic spindle.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=15562536</bp:url>
</bp:PublicationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_8887416e505bbf5700531991d1c153a0">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGA2</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">HMGA2 (mouse)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_8887416e505bbf5700531991d1c153a0</bp:comment>
</bp:Protein>

<bp:ProteinReference rdf:about="http://pathwaycommons.org/pc12/ProteinReference_b956204933388ca20b98452a46372612">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_Q61214" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">DYRK1A</bp:displayName>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/ProteinReference_b956204933388ca20b98452a46372612</bp:comment>
</bp:ProteinReference>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_5c581dc8fdb520f4d8032a389dbfdc55">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LY96</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LY96 (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_5c581dc8fdb520f4d8032a389dbfdc55</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_3cb4f57af657a752f52ba401c7db69b3">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/21957166" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_3cb4f57af657a752f52ba401c7db69b3</bp:comment>
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_0a2eb0ec-7b2a-4b19-9831-c428cd2a2577http___www_phosphosite_org_phosphosite_owl_recid_3359098">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_0a2eb0ec-7b2a-4b19-9831-c428cd2a2577http___www_phosphosite_org_phosphosite_owl_recid_3359098</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4117; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, gastrointestinal tract/untreated; &lt;b&gt;Disease:&lt;/b&gt; gastric carcinoma; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359098</bp:url>
</bp:PublicationXref>

<bp:BiochemicalReaction rdf:about="http://pathwaycommons.org/pc12/BiochemicalReaction_d321dff65d9765c70c89de03a6984dd1">
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_019694cee100883b8c6758647e2f213b" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_137ed609724abfb63003f9aa8592e6c7" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_be4d52bf63a0103ee44c523d8ae3c06a" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_89266e8cdebccd2627fef740047e6d46" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_f461e2c36c1f155b390ae76a94f68852" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_bb5e93b4b2f36de7530c46b0ee53f1eb" />
 <bp:evidence rdf:resource="http://pathwaycommons.org/pc12/Evidence_71da71856973cede6166d949dba02707" />
 <bp:right rdf:resource="http://pathwaycommons.org/pc12/Protein_8887416e505bbf5700531991d1c153a0" />
 <bp:left rdf:resource="http://pathwaycommons.org/pc12/Protein_c33fd2605eaba48f349e90ccd7b7fdf8" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/BiochemicalReaction_d321dff65d9765c70c89de03a6984dd1</bp:comment>
 <bp:conversionDirection rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LEFT_TO_RIGHT</bp:conversionDirection>
</bp:BiochemicalReaction>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24033439">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2014</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24033439</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer&apos;s disease and Down syndrome.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=29552547</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/29950669">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2018</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">29950669</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer&apos;s disease.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=705955102</bp:url>
</bp:PublicationXref>

<bp:RelationshipXref rdf:about="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_CDK1_identity">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CDK1</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hgnc symbol</bp:db>
</bp:RelationshipXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_73f528155d669989e67f2dcadb5d1017">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20833797" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_73f528155d669989e67f2dcadb5d1017</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24312574">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24312574</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Bimolecular fluorescence complementation; lighting-up tau-tau interaction in living cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=30350145</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/19659459">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19659459</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer&apos;s disease.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9721218</bp:url>
</bp:PublicationXref>

<bp:ProteinReference rdf:about="http://identifiers.org/uniprot/P07948">
 <bp:standardName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tyrosine-protein kinase Lyn</bp:standardName>
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_LYN_identity" />
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P07948" />
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN_HUMAN</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p53Lyn</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">p56Lyn</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">V-yes-1 Yamaguchi sarcoma viral related oncogene homolog</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">2.7.10.2</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">JTK8</bp:name>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Lck/Yes-related novel protein tyrosine kinase</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN_HUMAN Reviewed; 512 AA.</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://www.phosphosite.org/phosphosite.owl#po_618</bp:comment>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">FUNCTION: Non-receptor tyrosine-protein kinase that transmitssignals from cell surface receptors and plays an important role inthe regulation of innate and adaptive immune responses,hematopoiesis, responses to growth factors and cytokines, integrinsignaling, but also responses to DNA damage and genotoxic agents.Functions primarily as negative regulator, but can also functionas activator, depending on the context. Required for theinitiation of the B-cell response, but also for its down-regulation and termination. Plays an important role in theregulation of B-cell differentiation, proliferation, survival andapoptosis, and is important for immune self-tolerance. Actsdownstream of several immune receptors, including the B-cellreceptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A,TLR2 and TLR4. Plays a role in the inflammatory response tobacterial lipopolysaccharide. Mediates the responses to cytokinesand growth factors in hematopoietic progenitors, platelets,erythrocytes, and in mature myeloid cells, such as dendriticcells, neutrophils and eosinophils. Acts downstream of EPOR, KIT,MPL, the chemokine receptor CXCR4, as well as the receptors forIL3, IL5 and CSF2. Plays an important role in integrin signaling.Regulates cell proliferation, survival, differentiation,migration, adhesion, degranulation, and cytokine release. Down-regulates signaling pathways by phosphorylation of immunoreceptortyrosine-based inhibitory motifs (ITIM), that then serve asbinding sites for phosphatases, such as PTPN6/SHP-1, PTPN11/SHP-2and INPP5D/SHIP-1, that modulate signaling by dephosphorylation ofkinases and their substrates. Phosphorylates LIME1 in response toCD22 activation. Phosphorylates BTK, CBL, CD5, CD19, CD72, CD79A,CD79B, CSF2RB, DOK1, HCLS1, LILRB3/PIR-B, MS4A2/FCER1B, SYK andTEC. Promotes phosphorylation of SIRPA, PTPN6/SHP-1, PTPN11/SHP-2and INPP5D/SHIP-1. Mediates phosphorylation of the BCR-ABL fusionprotein. Required for rapid phosphorylation of FER in response toFCER1 activation. Mediates KIT phosphorylation. Acts as aneffector of EPOR (erythropoietin receptor) in controlling KITexpression and may play a role in erythroid differentiation duringthe switch between proliferation and maturation. Depending on thecontext, activates or inhibits several signaling cascades.Regulates phosphatidylinositol 3-kinase activity and AKT1activation. Regulates activation of the MAP kinase signalingcascade, including activation of MAP2K1/MEK1, MAPK1/ERK2,MAPK3/ERK1, MAPK8/JNK1 and MAPK9/JNK2. Mediates activation ofSTAT5A and/or STAT5B. Phosphorylates LPXN on &apos;Tyr-72&apos;. Kinaseactivity facilitates TLR4-TLR6 heterodimerization and signalinitiation. {ECO:0000269|PubMed:10574931,ECO:0000269|PubMed:10748115, ECO:0000269|PubMed:10891478,ECO:0000269|PubMed:11435302, ECO:0000269|PubMed:11517336,ECO:0000269|PubMed:11825908, ECO:0000269|PubMed:14726379,ECO:0000269|PubMed:15795233, ECO:0000269|PubMed:16467205,ECO:0000269|PubMed:17640867, ECO:0000269|PubMed:17977829,ECO:0000269|PubMed:18056483, ECO:0000269|PubMed:18070987,ECO:0000269|PubMed:18235045, ECO:0000269|PubMed:18577747,ECO:0000269|PubMed:18802065, ECO:0000269|PubMed:19290919,ECO:0000269|PubMed:20037584, ECO:0000269|PubMed:7687428}.CATALYTIC ACTIVITY:Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-[protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136,Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216;EC=2.7.10.2; Evidence={ECO:0000255|PROSITE-ProRule:PRU10028,ECO:0000269|PubMed:11517336, ECO:0000269|PubMed:11825908,ECO:0000269|PubMed:7682714, ECO:0000269|PubMed:8064233};ACTIVITY REGULATION: Subject to autoinhibition, mediated byintramolecular interactions between the SH2 domain and the C-terminal phosphotyrosine. Phosphorylation at Tyr-397 is requiredfor optimal activity. Phosphorylated by CSK at Tyr-508;phosphorylation at Tyr-508 inhibits kinase activity. Kinaseactivity is modulated by dephosphorylation by PTPRC/CD45.Inhibited by Dasatinib, PP2, and SU6656.{ECO:0000269|PubMed:16920712, ECO:0000269|PubMed:7935444}.SUBUNIT: Interacts with TEC. Interacts (via SH2 domain) with FLT3(tyrosine phosphorylated). Interacts with LIME1 and with CD79Aupon activation of the B-cell antigen receptor. Interacts with theB-cell receptor complex. Interacts with phosphorylated THEMIS2.Interacts with EPOR. Interacts with MS4A2/FCER1B. Interaction (viathe SH2 and SH3 domains) with MUC1 is stimulated by IL7 and thesubsequent phosphorylation increases the binding between MUC1 andCTNNB1/beta-catenin. Interacts with ADAM15. Interacts with NDFIP2and more weakly with NDFIP1. Interacts with FASLG. Interacts withKIT. Interacts with HCLS1. Interacts with FCGR2B. Interacts withFCGR1A; the interaction may be indirect. Interacts with CD19,CD22, CD79A and CD79B. Interacts (via SH3 domain) with CBLC,PPP1R15A and PDE4A. Interacts with TGFB1I1. Interacts (via SH3domain) with PIK3R1, the regulatory subunit ofphosphatidylinositol 3-kinase; this interaction enhancesphosphatidylinositol 3-kinase activity. Interacts with CSF2RB, thecommon subunit of the IL3, IL5 and CSF2 receptors. Interacts withPAG1; identified in a complex with PAG1 and STAT3. Interacts withABL1. Interacts with PTPN6/SHP-1. Interacts (via SH3 domain) withSCIMP (via proline-rich region). Interacts with LPXN (via LD motif3) and the interaction is induced upon B-cell antigen receptor(BCR) activation. Interacts (via SH3-domain) with ANKRD54 (viaankyrin repeat region) in an activation-independent status of LYN.Forms a multiprotein complex with ANKRD54 and HCLS1. Interacts(via SH2 and SH3 domains) with UNC119; leading to LYN activation.Interacts with CD36. Interacts with LYN (By similarity).{ECO:0000250|UniProtKB:P25911, ECO:0000269|PubMed:10362357,ECO:0000269|PubMed:10574931, ECO:0000269|PubMed:10748115,ECO:0000269|PubMed:11306681, ECO:0000269|PubMed:11517336,ECO:0000269|PubMed:11825908, ECO:0000269|PubMed:12496276,ECO:0000269|PubMed:12750561, ECO:0000269|PubMed:16912036,ECO:0000269|PubMed:16920712, ECO:0000269|PubMed:17233630,ECO:0000269|PubMed:17640867, ECO:0000269|PubMed:17977829,ECO:0000269|PubMed:18070987, ECO:0000269|PubMed:18235045,ECO:0000269|PubMed:19718658, ECO:0000269|PubMed:19807924,ECO:0000269|PubMed:19857964, ECO:0000269|PubMed:20037584,ECO:0000269|PubMed:20534535, ECO:0000269|PubMed:21930792,ECO:0000269|PubMed:7682714, ECO:0000269|PubMed:7687428,ECO:0000269|PubMed:8064233, ECO:0000269|PubMed:9232445,ECO:0000269|PubMed:9341198}.SUBUNIT: (Microbial infection) Interacts with Epstein-Barr virusLMP2A. {ECO:0000269|PubMed:7895172}.SUBUNIT: (Microbial infection) Interacts with Herpes virus saimirityrosine kinase interacting protein (Tip).{ECO:0000269|PubMed:11955060, ECO:0000269|PubMed:16155203}.SUBCELLULAR LOCATION: Cell membrane. Nucleus. Cytoplasm.Cytoplasm, perinuclear region. Golgi apparatus. Membrane{ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Accumulates in thenucleus by inhibition of CRM1-mediated nuclear export. Nuclearaccumulation is increased by inhibition of its kinase activity.The trafficking from the Golgi apparatus to the plasma membraneoccurs in a kinase domain-dependent but kinase activityindependent manner and is mediated by exocytic vesiculartransport. Detected on plasma membrane lipid rafts.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=2;Name=1; Synonyms=LYN A, p56lyn;IsoId=P07948-1; Sequence=Displayed;Name=2; Synonyms=LYN B, p53lyn;IsoId=P07948-2; Sequence=VSP_005002;TISSUE SPECIFICITY: Detected in monocytes (at protein level).Detected in placenta, and in fetal brain, lung, liver and kidney.Widely expressed in a variety of organs, tissues, and cell typessuch as epidermoid, hematopoietic, and neuronal cells. Expressedin primary neuroblastoma tumors. {ECO:0000269|PubMed:3561390,ECO:0000269|PubMed:8064233}.DOMAIN: The protein kinase domain plays an important role in itslocalization in the cell membrane. {ECO:0000269|PubMed:15173188}.PTM: Ubiquitinated by CBL, leading to its degradation.Ubiquitination is SH3-dependent. {ECO:0000269|PubMed:16920712,ECO:0000269|PubMed:20534535}.PTM: Autophosphorylated. Phosphorylated on tyrosine residues inresponse to KIT signaling. Phosphorylation at Tyr-397 is requiredfor optimal activity. Phosphorylation at Tyr-508 inhibits kinaseactivity. Phosphorylated at Tyr-508 by CSK. Dephosphorylated byPTPRC/CD45. Becomes rapidly phosphorylated upon activation of theB-cell receptor and the immunoglobulin receptor FCGR1A.{ECO:0000269|PubMed:18056483, ECO:0000269|PubMed:18070987,ECO:0000269|PubMed:18577747, ECO:0000269|PubMed:7935444,ECO:0000269|PubMed:8064233, ECO:0000269|PubMed:9171348,ECO:0000269|PubMed:9341198}.DISEASE: Note=Constitutively phosphorylated and activated in cellsfrom a number of chronic myelogenous leukemia (CML) and acutemyeloid leukemia (AML) patients. Mediates phosphorylation of theBCR-ABL fusion protein. Abnormally elevated expression levels oractivation of LYN signaling may play a role in survival andproliferation of some types of cancer cells.SIMILARITY: Belongs to the protein kinase superfamily. Tyr proteinkinase family. SRC subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License.</bp:comment>
</bp:ProteinReference>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/26161867">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2015</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26161867</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=49163700</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f65586e57b3d23377c0a31d6f447d980">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_799d80d6-4945-4a56-9854-b1a0d507aca7http___www_phosphosite_org_phosphosite_owl_recid_3360100" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f65586e57b3d23377c0a31d6f447d980</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_1d8960d084e81f6e5ad15f66f6488c27">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16115884" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_1d8960d084e81f6e5ad15f66f6488c27</bp:comment>
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_6080819dee1e6bd7379472c7aef48272">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/26555036" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_6080819dee1e6bd7379472c7aef48272</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f1656cc3e8f7fa8e4ed205582a96c53e">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/16877359" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f1656cc3e8f7fa8e4ed205582a96c53e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_molecular_interactions_ontology_MI_0113">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">MI:0113</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">molecular interactions ontology</bp:db>
</bp:UnificationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_90abf6c06949a765683cc6494d6597a1">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20886841" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_90abf6c06949a765683cc6494d6597a1</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/19651622">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">19651622</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9646508</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_c0c27c05da31297cc43600af30d0564d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/11104762" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_c0c27c05da31297cc43600af30d0564d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20394726">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20394726</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=14787100</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/26209608">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2016</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26209608</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Quantitative Mass Spectrometry Reveals that Intact Histone H1 Phosphorylations are Variant Specific and Exhibit Single Molecule Hierarchical Dependence.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=41581292</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_0937a133-9a54-4445-9212-1dc3408136f5http___www_phosphosite_org_phosphosite_owl_recid_4918530">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_0937a133-9a54-4445-9212-1dc3408136f5http___www_phosphosite_org_phosphosite_owl_recid_4918530</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 5467; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, Jurkat/calyculin_A &amp; pervanadate; &lt;b&gt;Disease:&lt;/b&gt; T cell leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; (K/R)XpSX(K/R)&lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-(Ser) PKC Substrate Antibody Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=2261&gt;2261&lt;/a&gt;, PTMScan(R) Phospho-PKC Substrate Motif (K/RXpSXK/R) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1985&gt;1985&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=4918530</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_37b71da8468846903c8286b0a58ac70b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/17971449" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_37b71da8468846903c8286b0a58ac70b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20139300">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20139300</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=12558707</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/23836654">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2013</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">23836654</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=33578800</bp:url>
</bp:PublicationXref>

<bp:RelationshipXref rdf:about="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_CHEK1_identity">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">CHEK1</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hgnc symbol</bp:db>
</bp:RelationshipXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_1b0839a064b1b56d7223f1eca041190e">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_047a3d13-e45a-44aa-bfe9-195aaf1ffab7http___www_phosphosite_org_phosphosite_owl_recid_3359080" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_1b0839a064b1b56d7223f1eca041190e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_df772a98f300a640b54217eaa50b458d">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_be2e199d-7473-4543-99c1-bbccccf7c5b4http___www_phosphosite_org_phosphosite_owl_recid_3360080" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_df772a98f300a640b54217eaa50b458d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_2e0f3858088328eb63c2a29837f44c9b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15822905" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_2e0f3858088328eb63c2a29837f44c9b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21857030">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21857030</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Quantitative phospho-proteomics to investigate the polo-like kinase 1-dependent phospho-proteome.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=21040928</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_5b9bf12ea5718a075cc8edb6a11e5593">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/12801934" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_5b9bf12ea5718a075cc8edb6a11e5593</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/25681442">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2015</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">25681442</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=40233034</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24275569">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2014</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24275569</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=33679700</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_372549b5cc6447eccd6da83f90ffcdcb">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19690332" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_372549b5cc6447eccd6da83f90ffcdcb</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_cb98d8eb5cde4fbfb39e6fbd9eeebe4e">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_0937a133-9a54-4445-9212-1dc3408136f5http___www_phosphosite_org_phosphosite_owl_recid_4918530" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_cb98d8eb5cde4fbfb39e6fbd9eeebe4e</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_47c6ce94fa7cb780bb21fff1400fbffe">
 <bp:xref rdf:resource="http://pathwaycommons.org/pc12/PublicationXref_a5c3e993-bb2b-4a80-91a6-e4696ae14c9ahttp___www_phosphosite_org_phosphosite_owl_recid_3358530" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_47c6ce94fa7cb780bb21fff1400fbffe</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_f3b59a19bcd074c4cd71d7a62c04e40c">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15621037" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_f3b59a19bcd074c4cd71d7a62c04e40c</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_8a835939-5678-4a5f-98d5-21e75085536fhttp___www_phosphosite_org_phosphosite_owl_recid_9392247">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_8a835939-5678-4a5f-98d5-21e75085536fhttp___www_phosphosite_org_phosphosite_owl_recid_9392247</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 7163; &lt;b&gt;Year:&lt;/b&gt; 2009; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, brain/untreated; &lt;b&gt;Disease:&lt;/b&gt; -; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; pY &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9411&gt;9411&lt;/a&gt;, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1991&gt;1991&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9392247</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_7b014925-1378-4ed4-9650-d3d25697b1ffhttp___www_phosphosite_org_phosphosite_owl_recid_9390970">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2009</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_7b014925-1378-4ed4-9650-d3d25697b1ffhttp___www_phosphosite_org_phosphosite_owl_recid_9390970</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 6543; &lt;b&gt;Year:&lt;/b&gt; 2009; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; cell line, Jurkat/TPA; &lt;b&gt;Disease:&lt;/b&gt; T cell leukemia; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-(Ser/Thr) PKD Substrate Antibody Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=4381&gt;4381&lt;/a&gt;, PTMScan(R) Phospho-PKD Substrate Motif (LXRXXpS/pT) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1986&gt;1986&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=9390970</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_2a087c70-081b-42c5-a7fe-fe27d89a8567http___www_phosphosite_org_phosphosite_owl_recid_3360282">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_2a087c70-081b-42c5-a7fe-fe27d89a8567http___www_phosphosite_org_phosphosite_owl_recid_3360282</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 3912; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, liver/untreated; &lt;b&gt;Disease:&lt;/b&gt; liver cancer; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3360282</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/20815410">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2010</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">20815410</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=17335003</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_b30636df5cc3057220737d5cd4252ca2">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/15621037" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_b30636df5cc3057220737d5cd4252ca2</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_cf27fb1da9e471e1bc15f5d495fb0c12">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/29760653" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_cf27fb1da9e471e1bc15f5d495fb0c12</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_a9572d7333356aa1369660834d9d028d">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/18315566" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_a9572d7333356aa1369660834d9d028d</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_28b207cfbccb2f4231c4d82dd1f944a2">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLM</bp:displayName>
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PLM (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_28b207cfbccb2f4231c4d82dd1f944a2</bp:comment>
</bp:Protein>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/24719451">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2014</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">24719451</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=34666515</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/10981712">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2000</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">10981712</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Phosphorylation of telokin by cyclic nucleotide kinases and the identification of in vivo phosphorylation sites in smooth muscle.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=8843</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_b850b4e60cc6108d1f97598d191e2721">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/11104762" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_b850b4e60cc6108d1f97598d191e2721</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8a18552dfab107cf765aacea1d97d920" />
</bp:Evidence>

<bp:RelationshipXref rdf:about="http://pathwaycommons.org/pc12/RelationshipXref_hgnc_symbol_INSR_identity">
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">INSR</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">hgnc symbol</bp:db>
</bp:RelationshipXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_019694cee100883b8c6758647e2f213b">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20139300" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_019694cee100883b8c6758647e2f213b</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:UnificationXref rdf:about="http://pathwaycommons.org/pc12/UnificationXref_uniprot_knowledgebase_P07948">
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">PRIMARY</bp:comment>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">P07948</bp:id>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">uniprot knowledgebase</bp:db>
</bp:UnificationXref>

<bp:Protein rdf:about="http://pathwaycommons.org/pc12/Protein_d8a8eba80f0605e86aaa096c4c3961eb">
 <bp:displayName rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN</bp:displayName>
 <bp:entityReference rdf:resource="http://identifiers.org/uniprot/P07948" />
 <bp:name rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">LYN (human)</bp:name>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Protein_d8a8eba80f0605e86aaa096c4c3961eb</bp:comment>
</bp:Protein>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_880f4b6855fe65e87ac2c7092816497a">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19472218" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_880f4b6855fe65e87ac2c7092816497a</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_8e1e80bfab79984903b7e3804345048e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://pathwaycommons.org/pc12/PublicationXref_6000f091-4d80-42a9-85a4-ad5e95fdfdbbhttp___www_phosphosite_org_phosphosite_owl_recid_3359092">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2008</bp:year>
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/PublicationXref_6000f091-4d80-42a9-85a4-ad5e95fdfdbbhttp___www_phosphosite_org_phosphosite_owl_recid_3359092</bp:comment>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">&lt;b&gt;CST Curation Set:&lt;/b&gt; 4116; &lt;b&gt;Year:&lt;/b&gt; 2008; &lt;b&gt;Biosample/Treatment:&lt;/b&gt; tissue, gastrointestinal tract/untreated; &lt;b&gt;Disease:&lt;/b&gt; gastric carcinoma; &lt;b&gt;SILAC:&lt;/b&gt; -; &lt;b&gt;Specificities of Antibodies Used to Purify Peptides prior to LCMS:&lt;/b&gt; RXXp[ST] &lt;b&gt;Antibodies Used to Purify Peptides prior to LCMS: &lt;/b&gt; Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=9614&gt;9614&lt;/a&gt;, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: &lt;a href=http://www.cellsignal.com/product/productDetail.jsp?productId=1978&gt;1978&lt;/a&gt;</bp:title>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=3359092</bp:url>
</bp:PublicationXref>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/25378699">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2014</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">25378699</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=36671634</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_88c7a2d9c534b420498edfc6279d7255">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/19472218" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_88c7a2d9c534b420498edfc6279d7255</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/26692334">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2016</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">26692334</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=53406504</bp:url>
</bp:PublicationXref>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_e3e57c05dc5f8ef7370de45f70f759e3">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/12765608" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_e3e57c05dc5f8ef7370de45f70f759e3</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_71fe7be44e80879bb8505ec68b171f5c" />
</bp:Evidence>

<bp:Evidence rdf:about="http://pathwaycommons.org/pc12/Evidence_8755f22d841f3dbac268936590a3dc32">
 <bp:xref rdf:resource="http://identifiers.org/pubmed/20860994" />
 <bp:comment rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">REPLACED http://pathwaycommons.org/pc12/Evidence_8755f22d841f3dbac268936590a3dc32</bp:comment>
 <bp:evidenceCode rdf:resource="http://pathwaycommons.org/pc12/EvidenceCodeVocabulary_b5e00d0cdfd43a81f726c070c956473e" />
</bp:Evidence>

<bp:PublicationXref rdf:about="http://identifiers.org/pubmed/21406692">
 <bp:year rdf:datatype = "http://www.w3.org/2001/XMLSchema#int">2011</bp:year>
 <bp:id rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">21406692</bp:id>
 <bp:title rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</bp:title>
 <bp:db rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">pubmed</bp:db>
 <bp:url rdf:datatype = "http://www.w3.org/2001/XMLSchema#string">http://www.phosphosite.org/curatedInfoAction.do?record=18795900</bp:url>
</bp:PublicationXref>
</rdf:RDF>